Rabu, 8 Mei 2013

Clinical Chemistry


Clinical Chemistry

Chemical analyses are useful diagnostic and therapeutic measurements upon which clinicians depend for reliable diagnosis and patient management. Clinical Chemistry is concerned primarily with quantitative analysis of substances found in blood or blood serum. Other fluids such as urine, spinal fluid and pleural fluid are often analyzed. The substances for which the analyses are performed are known as analytes.

Analytes are often classified by type:

    Analyte Type             Examples

    Electrolytes             Na+, K+, Cl-, HCO3-, PO4-3, Ca+2, Mg+2, etc.

    Enzymes                  Alkaline Phosphatase, Acid Phosphatase, Creatine Phosphokinase,
                             Lactic Acid Dehydrogenase, Glutamic-Oxalacetic Transaminase,
                             Amylase, etc.

    Proteins                 Total protein, Albumin, Globulin, Pre-albumin, Alpha globulins,
                             Beta Globulins, Immunoglobulins, etc.

    Organics                 Glucose, Urea, Uric Acid, Creatinine, Acetone, Cholesterol, etc.


A more useful classification of analytes organizes analytes by organ or diagnostic profiles:

    Profile Type             Composition of Example Profiles

    Renal (kidney)           Na+, K+, Cl-, HCO3-, PO4-3, Urea nitrogen, Creatinine, Uric acid,
                             Albumin

    Hepatic (liver)          Total Bilirubin, Direct Bilirubin, AST, ALT, ALP, Cholesterol,
                             Total Protein, Albumin, Globulin

    Cardiac (heart)          CPK, LDH, Beta-HBD, Troponin I, Troponin T, CPK-MB, Myoglobin

    Hypertensive             Cholesterol, HDL (HDL-cholesterol), LDL (LDL-cholesterol),
     (circulatory)           VLDL (VLDL-cholesterol), Triglycerides, Renin

    Thyroid                  Thyroxin, Free Thyroxin, Thyroid Uptake or Tri-iodothyronine,
                             TSH (Thyroid Stimulating Hormone)

    Basic Metabolic          Na+, K+, Cl-, HCO3-, Ca+2, Urea nitrogen, Creatinine, Glucose

    Comprehensive Metabolic  Na+, K+, Cl-, HCO3-, Ca+2, Urea nitrogen, Creatinine, Glucose,
                             Bilirubin, AST, Total Protein, Albumin, Cholesterol, ALP

Hematology and Hemostasis



Hematology and Hemostasis


In its broadest interpretation hematology is the study of blood.

Blood is a complex mixture of suspended cellular components (erythrocytes, leukocytes and thrombocytes) and dissolved substances (electrolytes, proteins, carbohydrates, amino acids, etc.). Clinical hematology is concerned primarily with the cellular components of blood.

If blood is withdrawn from a vein and placed in a plain, untreated test tube, the blood will clot. Blood specimens of this type are used to harvest blood serum for testing. After the blood has clotted (5-20 minutes) the tube is centrifuged to compact the clotted cellular mass which is more dense than the supernatant serum. The supernatant serum is then aspirated and used for chemical or immunological testing. If a fresh blood specimen is promptly mixed with an anticoagulant (there are several: oxalates, citrates, ethylene diamine tetraacetates, heparins), the whole blood will remain fluid, allowing the cells to remain homogenously suspended in the blood plasma. If the anticoagulated whole blood specimen is allowed to stand for a sufficient length of time or the specimen is centrifuged, the cells will sediment to the bottom of the test tube, leaving a supernatant fluid called blood plasma. The sedimented tube may be mixed to resuspend the cells to a state nearly identical to circulating whole blood. Anticoagulated whole blood specimens are required for most hematology testing, i.e., cell counts, etc. The principle difference between serum and plasma is that serum contains no fibrinogen. The fibrinogen is consumed in its conversion to an insoluble fibrin matrix which traps the cells and forms the clot.
The photo at right shows a rack of tubed blood specimens. The red-stoppered tubes contain serum and a centrifuged clot. The green-stoppered tubes contain centrifuged, heparin-anticoagulated whole blood.

Common measurements in hematology are quantitative and qualitative measurement of RBC's, hemoglobin content, total WBC count, differential WBC and platelet count.

Erythrocytes are the hemoglobin-containing Red Blood Cells (or RBC corpuscles) which are necessary for the transport of oxygen from the lungs to the tissues and for the transport of carbon dioxide from the tissues to the lungs. Leukocytes (or
White Blood Cells; WBC) are of several types, performing functions such as phagocytosis and synthesis of immunoglobulins. Thrombocytes (or platelets) are cellular fragments employed for hemostasis (clotting) in hemorrhage. RBC's, platelets, the granulated leukocytes, B-lymphocytes, N-lymphocytes and Monocytes originate in bone marrow, undergoing differentiation and specific maturation. T-lymphocytes originate in the Thymus. Some lymphocytes are non-terminal, living for as long as 30 years. Monocytes are transitional cells, living in the circulation only briefly (ca. 14 hours). They migrate into the tissues where they are transformed into macrophages. See the photomicrograph below.
Neutrophils phagocytize bacteria and increase in number in acute bacterial infections. Monocytes increase in number in chronic bacterial infections and neutropenia. Lymphocytes are immune leukocytes and increase in viral infections. Eosinophils are increased in alergic reactions and parasitic infections. Basophils are associated with inflammation, acute alergic reactions and chemotaxis.

Moderately large increases in lymphocytes (leukemoid reaction) are associated with infectious lymphocytosis (infections by adenovirus, enterovirus or Coxsackie A virus).

Very large increases of leukocytes are associated with specific leukemias, eg. acute lymphocytic or myelogenous leukemias. These are confirmed by bone marrow biopsy.

Adjacent is a typical CBC (Complete Blood Count or Hemogram) consisting of WBC, RBC, Hemoglobin, Platelet, RBC Indices and Differential WBC. Note that evaluation of the CBC components is based on comparison to established Normal or Reference Ranges (low, normal and high). Furthermore, many test's reference ranges are either sex or age dependent, or both. The clinical significance of laboratory findings is interpreted by medical practitioners (primarily physicians) to assist in the diagnosis and treatment of their patients.

Today, the measurements of the cellular components of blood are very much automated by elaborate, computerized instruments. The instrument below is a Beckman-Coulter MAXM which is capable of performing an automated CBC. All of the tasks which would be required for manual "wet-bench" methods of performance of a CBC have been incorporated in this instrument; precise sampling, mixing with appropriate reagent volumes, cell counting and sizing, and hemoglobin measurement are performed on bar-coded samples, and the results are collated and printed locally and to remote printers and fax machines with little user intervention.


Wet-bench methods are still in use in small remote labs in this country and abroad. Every medical technology student must perform these manual methods prerequisite to an understanding of automated methods. Hemoglobin is converted to cyanmethemoglobin and measured photometrically. Blood is diluted into an isotonic saline solution, loaded into a ruled counting chamber, and the RBC's and platelets are counted microscopically. Blood is diluted into a dilute acid solution to rupture the RBC's, leaving the WBC's intact for counting microscopically. A thin blood smear on a microscope slide is stained with Wright's stain, and then a differential WBC count is performed microscopically. Click here for the details of a manually performed CBC.
The reticulocyte (abbreviated "retic") count is another manual hematology test which has been automated. Reticulocytes are immature RBC's containing RNA prematurely released into the circulatory system from the bone marrow as a usual response to some anemias or blood loss. In the absence of anemia there is normally a small percentage of the RBC's which are reticulated. The manual version of this test consists of staining RBC's with New Methelene Blue (a supravital stain, i.e., a stain which stains living cells), and preparing a thin film of the stained RBC's on a microscope slide. The stained reticulocytes are counted and expressed as a percentage of the total RBC's.
Sickle cell screening tests for the presence of Hemoglobin-S, one of several hemoglobin variants. Hemoglobin S is formed as the result of a single-gene defect causing substitution of valine for glutamic acid in position 6 of the beta chain of adult hemoglobin. Persons homozygous for hemoglobin S (HbSS) have sickle cell anemia. Hemoglobin-S is found in individuals of African descent. "Sickle cells" obtain their name from the characteristic sickle shape that Hemoglobin-S-containing RBC's assume under decreased oxygen tension. The screening for Hemoglobin-S employs its decreased solubility in a buffered Sodium
Hydrosulfite solution for detection. Hemoglobin variants are confirmed by hemoglobin electrophoresis, a modified chromatography procedure wherein hemoglobin homologs are separated under the influence of an electric potential. Adjacent is a photomicrograph of a Wright-stained blood smear from an individual in "Sickle Cell Crisis". 


HEMOSTASIS


Blood is of prime importance in the normal physiologic function of our major organ systems. In order for it to be effective, blood must be in a liquid or non-coagulated state. Another important function of blood is to maintain an intact circulatory system following trauma. The process by which blood is maintained fluid within the vessel walls and the ability of the system to prevent excessive blood loss upon injury is termed hemostasis. The balance between the forces that cause blood to solidify or to remain fluid is very delicate and involves several interacting systems.

When you cut yourself, the process of coagulation begins by the formation of a blood clot. This is followed shortly after by digestion or breakdown of the clot. Patients clot and/or bleed because of a variety of identifiable hemostatic abnormalities. Logical and effective treatment depends upon the proper identification of the abnormality. The coagulation or hemostasis laboratory performs tests to determine the cause and to monitor the proper treatment of the defect.

Platelets, Vascular and Clotting Factors - a brief discussion of their function 

      Platelets - 
           small, anuclear cytoplasmic disks. In an unstimulated state, the shape
           is discoid.
      Hemostasis - 
           the process in circulation where the blood is maintained fluid in vessels and
           without major loss in case of injury.
      Coagulation factors -
           Components that exist in the circulation and supply the necessary constituents
           for clot formation.

Hemostasis: The property of the circulation where the circulating fluid is maintained within the blood vessels is referred to as hemostasis. The process depends on a delicate and complex interplay of at least 4 systems: vascular, plasma coagulation factors, platelets and fibrinolytic system.

Simplified diagram of hemostasis


Vascular System: Blood normally flows smoothly through the vascular system without cellular adherence to the vessel wall. The thin layer of endothelial cells lining the inner surface of the various vessels helps to maintain a thrombo-resistant surface. When vascular injury occurs following trauma or in certain vessel diseases, the endothelial cells interact with platelets and clotting factors to form a blood clot at the site of injury.

Platelets and Hemostasis: The platelet has at least a fourfold function: (1) In response to vascular injury, platelets are stimulated to initiate the formation of a primary hemostatic plug, (2) the platelet contributes phospholipid (sometimes referred to as platelet factor 3 or PF3) to the coagulation cascade, (3) they help maintain vascular integrity through endothelial support and (4) platelets may have a role in inflammatory response, possibly by activating the fifth component of complement.

There is a sequence of events which occurs at the site of vascular injury. First, the platelet is attracted to the exposed sub-endothelial layer of collagen and adheres to it. To accomplish this, the platelet undergoes a shape change. Secondly, the platelets release intrinsic adenosine diphosphate (ADP), among other substances. The released ADP stimulates other platelets to stick together at the wound site, and, thirdly, aggregation occurs. In this process, platelets adhere to each other to form a beginning plug. Finally, coagulation occurs and fibrin forms around the platelet aggregate to initiate repair. (See figure 1)

Coagulation Factors: The coagulation factors circulate in the plasma as cofactors or as procoagulants, and, when activated supply some of the components needed for clot formation. According to the international nomenclature system, coagulation cofactors and procoagulants were assigned roman numerals in the order of their discovery and don't correspond to their location in the coagulation sequence of activation. (See figure 2) The coagulation factors are generated in the liver cells, except for Factor VIII (at least the Von Willebrand's portion), which is produced in multiple organs, possibly the endothelial cells and megakarocytes.

The model generally used to describe the mechanism of coagulation is the cascade system. The cascade is separated into three areas: the intrinsic system, commonly measured by the aPTT test, which is activated by surface contact; the extrinsic system, commonly measured by the PT test, which is activated by vascular injury, and, the common pathway, which is set into motion by activation from the intrinsic and/or the extrinsic pathway. Because of the variety of constituents involved with the common pathway, there are several different tests that could be used to monitor activity. The systems and tests are described later.

Primary Hemostasis: Following injury to a blood vessel, all of the systems are activated. For sake of ease, the hemostatic process is divided into 2 components; primary hemostasis and secondary hemostasis. Primary hemostasis depends upon the response of the platelet and blood vessel wall to the injury. When the small blood vessels are injured, blood platelets adhere and aggregate at the site of injury, reducing and finally arresting bleeding.

Secondary Hemostasis: Secondary Hemostasis starts when the cascade system of Coagulation is activated by substances released at the time of blood vessel injury.

These coagulation factors, which are proteins, with the exception of Calcium and Thromboplastin, can conveniently be divided into three families: the fibrinogen, prothrombin, and contact family. The fibrinogen family includes fibrinogen, Factors V, VIII, and XIII. The prothrombin family includes Factors II, VII, IX, X, Protein C and Protein S. The contact family of plasma coagulation proteins include: Factor XII or Hageman factor, Factor XI, Fletcher factor or Prekallikrein (PK), Fitzgerald factor or High Molecular Weight Kininogen (HMWK) and possibly the Passovoy factor. They are all involved in the mechanism that generates insoluble fibrin as a final product, by means of the coagulation cascade. Disorders of secondary hemostasis many times involve a change in the coagulation proteins. These changes can be a decreased level of a particular factor or a defect in the way the factor functions.


Extrinsic Pathway 

      Enzyme: 
           Organic compound, frequently a protein, capable of accelerating or producing by
           catalytic action some change in a substrate for which it is often specific.
      Extrinsic pathway: 
           Pathway in which fibrin is formed as the result of the release of tissue
           thromboplastin into the circulation.
      Prothrombin time: A laboratory coagulation test which measures the general level
           of clottability of a plasma sample. It is sensitive to the factors of the
           extrinsic clotting system.
      INR:
           International Normalized Ratio which provides a convenient method for
           standardizing the monitoring of Warfarin therapy.

Hemostasis is defined as a property of circulation whereby blood is maintained within a vessel and the ability of the system to prevent excessive blood loss when injured. One of the major components needed to provide hemostasis is the coagulation system which involves the clotting proteins or clotting factors. The coagulation factors, except for calcium and thromboplastin, are proteins and are involved in a sequential reaction or coagulation cascade. The last step of the cascade leads to insoluble fibrin as the end product. The reactions leading to fibrin formation can be divided into the extrinsic, intrinsic and common pathways. The extrinsic pathway is initiated by the release of tissue thromboplastin (Factor III) which is exposed to the blood when there is damage to the blood vessel. Factor VII which is a circulation coagulation factor, forms a complex with tissue thromboplastin and calcium. This complex rapidly converts Factor X to the enzyme form Factor Xa. Factor Xa catalyzes the prothrombin (Factor II) to thrombin (Factor IIa) reaction which is needed to convert fibrinogen (Factor I) to fibrin. See figure 3 for "coagulation cascade" diagram depicting the extrinsic, intrinsic and common pathways. The Prothrombin Time or PT is a laboratory screening test used to detect coagulation disorders. It measures the activity of the factors of the extrinsic pathway including factors II, V, VII, X, and fibrinogen. The extrinsic factors not measured in the PT test are Factors III (Thromboplastin), and IV (Calcium). The PT is also used to monitor oral anticoagulant therapy such as warfarin.

Warfarin is a drug used in patient therapy to prevent thrombosis. It inhibits the synthesis of the vitamin K dependent factors, factors II, VII, IX and X by blocking the regeneration of vitamin K and shows a dose dependent effect. As more warfarin is ingested orally, the greater the reduction in the functional levels of vitamin K dependent factors. See figure 4 for the effect of warfarin on the synthesis of clotting factors. Because 3 of the 4 factors affected by warfarin are evaluated by the PT test, it is commonly used to monitor therapy.

The PT test is performed by adding tissue thromboplastin and calcium to plasma and measuring the time for clot formation. It can be performed either manually by tilt tube method or mechanically by use of a fibrometer or a photo-optical instrument. The PT reagent used in the testing provides the tissue thromboplastin and calcium. The sources of thromboplastin can be human or rabbit brain, lung, placental, brain/lung combination, or produced by recombinant technology. The necessary calcium is added to the reagent either at the time of manufacture or prior to testing.

The PT can be done as either a one-stage or a two-stage assay, although the one-stage procedure is the most widely used and preferred. Thromboplastin reagent (0.2 ml) is warmed at 37C then forcibly added to plasma (0.1ml) which also has been heated to 37C and a timer is started. As soon as the clot forms indicating fibrin formation, the timing stops and the time is recorded to the nearest tenth of a second. The expected normal range for a PT is 10-14 seconds depending on the type of reagent used.

Variation in the composition and responsiveness of PT reagents have necessitated the use for standardization. The International Normalized Ratio or INR was developed for the purpose of standardizing the monitoring of warfarin therapy.

Several factors may contribute to the differing degrees of responsiveness observed for various thromboplastin reagents. Some of these include the species and tissue source, the relative concentrations of other components of the reagent formula etc. The responsiveness of the thromboplastin reagent needs to be considered to make the PT an effective way of monitoring warfarin treatment. The responsiveness of a thromboplastin reagent toward plasma samples from patients receiving warfarin is described by a value called the International Sensitivity Index (ISI).

The calculation of the INR is obtained by using the following calculation:



The lower the ISI, the more responsive the reagent. The differences in the responsiveness of thromboplastins to the reduction of clotting factors II, VII and X are responsible for the difference in dosage of oral anticoagulants.

In summary, defects in the normal hemostatic mechanism can be listed as two types. One is the failure of any of the processes that lead to the hemostatic plug formation which may lead to a bleeding disorder and inappropriate activation of the hemostatic mechanism which may cause thrombosis. Laboratory investigations and determinations are needed to identify the exact nature of the underlying bleeding disorder. Screening tests such as the PT are initially performed. Based on these results, further, more complex testing may be needed leading to follow-up corrective action and treatment.


Intrinsic Pathway 

      Activated partial thromboplastin time (APTT) 
           One of the tests used for screening patients for a bleeding tendency.
           Specifically, adequate levels of the coagulation factors XII, XI, IX,
           VIII, X, V and II must be present for the test to be normal. The test also
           serves as the basis for other test procedures such as certain factor assay
           tests. 
      Intrinsic 
           Originating from within

The intrinsic pathway of Coagulation is activated when circulating Factor XII comes in contact with and is bound to a negatively charged surface. This causes a change in the molecular configuration of Factor XII and in concert with HMWK and prekallikrein it becomes an active enzyme, XIIa. This activated enzyme is then able to bring about a similar change in Factor XI. After activation, Factor XIa, in a calcium dependent reaction, converts Factor IX to its active form, Factor IXa. A phospholipid surface is also needed for Factor IXa conversion and is provided by activated platelets, as Platelet Factor Three (PF3). Factor IX can also be activated by the tissue factor, Factor VII complex; the initiating complex of the extrinsic pathway. Factor X can be activated to Factor Xa by either the Factor VIIa complex or by the complex of Factor IXa and Factor VIII. Factor Xa in the presence of Factor V, calcium and phospholipid surface converts Factor II (prothrombin) to Factor IIa (thrombin) which converts Factor I (fibrinogen) to fibrin(See figure 5).

Activated partial thromboplastin time (aPTT) is an assay used to screen for abnormalities of the intrinsic clotting system. It is also used to monitor the anticoagulant effect of circulating heparin.

An aPTT assay is performed by adding to platelet poor plasma a Factor XII activator, a phospholipid, and calcium ions. Factors I, II, V, VIII, IX, X, XI, XII, prekallikrein (Fletcher Factor) and high molecular weight kininogen (HMWK) are measured. An abnormal aPTT result might indicate the presence of an acquired inhibitor or a deficiency in any of the coagulation factors except Factors VII and XIII.

For in vitro analysis, some commonly used activators are glass, ellagic acid, kaolin, silica and celite. All of these except glass, are used in aPTT reagents and serve the same function of activating the clotting mechanism. Phospholipids are platelet substitutes and accelerate the reactions involved. Sources of phospholipids are rabbit brain, cephalin (dehydrated rabbit brain), bovine brain, and soy bean.

When adequate levels of all the coagulation factors are present in plasma, the aPTT test result is normal. Normal ranges of the factors vary from approximately 50-150% of normal. In general an aPTT reagent should be able to detect factor levels of 30% or less. If aPTT results are prolonged and there is no indication of a factor deficiency, an acquired inhibitor may be present.

Heparin will also cause a prolonged aPTT. This commercial product is prepared from beef lung or porcine intestinal mucosa and is administered via intravenous or subcutaneous injection. Heparin with its plasma co-factor Antithrombin III, inhibits coagulation immediately after being administered. It is the drug of choice for treating venous thrombosis by preventing fibrin formation.

The aPTT, although useful in monitoring high level heparin therapy, has had variable effectiveness in monitoring low dose heparin therapy and low molecular weight forms of heparin.

Natural Inhibitors 

      Antithrombin III 
           Natural inhibitor of the coagulation system 
      Protein C 
           Natural inhibitor of the coagulation system 
      Protein S 
           Protein C co-factor 

Once Coagulation is initiated, the body has mechanisms for avoiding massive thrombus formation. Physiologic balancing of the Hemostatic mechanism to limit uncontrolled bleeding and clotting is an important aspect in the Hemostatic response. There are a variety of biological control mechanisms which aid in the control of blood coagulation. These include the ability of the liver and the reticulo-endothelial system to clear activated clotting factors from the circulation, the prevention of the high concentrations of activated factors at a given location within the circulation by a constant blood flow, and natural inhibitors in the plasma such as Antithrombin III and the Protein C-S System.

Antithrombin III (AT-III) is the most important inhibitor of the coagulation enzymes. AT-III binds to activated factors rendering them inactive (Figure 6). The primary function is to inactivate thrombin. Inactive factors and cofactors are not neutralized by AT-III, since it only binds to the enzymatic factors. The process of binding the active forms of the clotting factors (XIIa, XIa, Xa, IXa) and thrombin to AT-III is greatly accelerated by heparin to an almost instant neutralization. AT-III inhibits not only coagulation enzymes but also plasmin and kallikrein.

Patients with decreased AT-III levels are subject to an increased risk of thromboembolism even in cases of slightly reduced AT-III levels, therefore the Antithrombin III assay is an important part of a prethrombotic workup.

Antithrombin III levels are affected by several other disease states. Individuals suffering from severe hepatic disorders such as cirrhosis or acute hepatitis have significantly depressed AT-III levels, while disease accompanied by inflammation may show elevations. Protein C is an inhibitor of the activated Factors Va and VIIIa. (See figure 6) This is its anticoagulant function. Protein C also inactivates tissue plasminogen activator inhibitor (PAI) which increases the activity of tissue plasminogen activator (tPA) which enhances fibrinolytic activity. Therefore, it can be said that Protein C has both anticoagulant and fibrinolytic functions. Just as Antithrombin III has a co-factor which is heparin, Protein C has a co-factor which is Protein S. Both Protein C and Protein S are vitamin K dependent factors. Enhancement of Protein C anticoagulant functions is achieved by Protein S. Patients with Protein C and/or Protein S deficiencies have a thrombotic tendency. Patients also may acquire deficiencies of Protein C and Protein S with liver disease and disseminated intravascular coagulation (DIC).


Fibrinolysis 

      Fibrinolysis: 
           Dissolution and localization of a fibrin clot.
      Plasmin:
           Active portion of fibrinolytic system: has the ability to dissolve formed fibrin
           clots; also has similar effect on other plasma proteins and clotting factors.

The last stage of coagulation is fibrinolysis, which is the dissolution and localization of a fibrin clot. These functions are carried out by enzymes and their inhibitors. A disruption or breach of the fine balance of this fibrinolytic system can result in bleeding or thrombosis.

The components of the fibrinolytic system are schematically shown in Figure 7. Fibrinolysis is mediated by activation of plasminogen to plasmin. This is accomplished by:


      Intrinsic activation (plasma based) initiated through Factor XIIa and allikrien.
      Thus, the contact system of coagulation serves as an intrinsic activator.

      Extrinsic activation (cellular based) initiated by way of stimuli such as vascular
      injury, ischemia, exercise, stress and pyrogens.

      Exogenous (Therapeutic) activation (drug based) includes streptokinase, urokinase and
      tPA tissue plasminogen activator).

Activators of plasminogen convert it to the active enzyme plasmin. Plasmin, in turn, acts to split the fibrin clot into fibrin degradation products. To balance this activity there are inhibitors. The most important inhibitor of plasminogen activators is PAI-1, which is fast acting. Alpha2-antiplasmin, another principal inhibitor of fibrinolysis, inhibits plasmin (See figure 8).

Soluble fibrinogen is cleaved by thrombin to form fibrin monomers. The fibrin monomers aggregate to form fibrin polymers, unstable fibrin clots. Thrombin also activates factor XIII to an activated enzyme, factor XIIIa, which in the presence of calcium converts fibrin polymers to a stable fibrin clot. Plasmin can degrade or split both fibrinogen and fibrin into fragments, X, Y, D and E. Fibrinogen degradation products (FDP) are the products of fibrinogenolysis and are detected by the FDP assay. Fibrin degradation products (fdp) are the product of fibrinolysis. The only time D-dimers (cross linked D-domains) are present is after the degradation of a stable fibrin clot (See figure 9).

There are many conditions that can affect the fibrinolytic system resulting in an increased or decreased activity of fibrinolysis. Samples of such conditions are Disseminated Intravascular Coagulation (DIC), trauma from surgical procedures or accidents, deficiencies in or consumption of the various inhibitors and activators of the fibrinolytic system.

Continued study of the fibrinolytic system unlocks it's complexities . Always on the horizons are newer and more sensitive and specific methods of evaluating this system, thus providing better diagnostic tools.


References: Hemostasis Basics, Dade Behring, 2000 

Phlebotomy


Phlebotomy


Occupational Description
The phlebotomist is primarily responsible for collecting blood specimens from patients for the purpose of laboratory analysis. He/She is also knowledgable about the health care delivery system; collection of materials and equipment; venipuncture and capillary puncture techniques; specimen transport and processing techniques; quality assurance and safety techniques; concepts of oral and written communications skills; and medical, legal and ethical implications of blood collection. Phlebotomists work in a variety of health care settings such as hospitals, clinics, rehabilitation facilities, long-term care facilities, extended care facilities, and industry.

Accreditation and Certification Phlebotomy programs are approved by the National Accrediting Agency for Clinical Laboratory Sciences (NAACLS), 8410 West Bryn Mawr Ave., Suite 670, Chicago, IL 60631-3415, phone number is (773) 714-8886. Students who successfully complete the Phlebotomy Program are eligible to take the national certification examinations given by either the National Certification Agency for Medical Laboratory Personnel (NCA) or the American Society of Clinical Pathologists, Board of Registry (ASCP).

  Patient Identification 
  Selection of Collection Site 
  Equipment 
  Procedure 


Patient Identification
Proper identification decreases the risk of harm to the patient. Proper identification can be determined by asking the patient to tell you his/her full name or through the utilization of the hospital ID band. Many institutions state in their procedure manuals that blood collection can not be done unless a ID band is present. It is important to be aware of the organization's policies and procedures.
Prior to specimen collection compare requisition with patient identification band.

In outpatient or other settings when no identification band is available, ask the patient to
state their full name. Do not state their name and ask if that is correct.  Check the
requisition and patient identification again after specimen collection is complete. 


Selection of collection site

Collection site selection involves consideration of several factors. 

     Select a vein that is readily palpated. 
     Do not select a site above an indwelling IV. 
     Do not select a site on the side of a mastectomy. 
     Do not select a site on the arm of the AV fistula of a dialysis patient. 
     Do not select a site with a hematoma or bruise.

Equipment The following are suggested supplies for blood specimen collection. Non sterile exam gloves Puncture resistant sharps container. Alcohol wipes. Tourniquet. Appropriate specimen collection lab tubes. 2x2 gauze. Tape. Vacutainer holder. Vacutainer needle. Procedure Univeral Precautions should be employed during any specimen collection. The following is a suggested method of performing blood specimen collection. 1.Make positive patient identification. 2.Gather necessary equipment 3.Wash your hands. 4.Don non sterile exam gloves. 5.Explain test and planned procedure to patient. 6.Position patient's arm in comfortable position. 7.Select appropriate collection site. 8.Place the tourniquet above the selected collection site. Do not leave tourniquet on for longer than for one minute. 9.Clean site with alcohol using circular motion from center outward. 10.Grasp arm 1-2 inches below the site to decrease vein rolling. 11.Enter the vein with the vacutainer needle bevel up at a 15 degree angle. 12.Fill necessary specimen containers. 13.Release tourniquet. 14.Place sharps in puncture resistant sharps container. 15.Apply gauze and tape holding pressure for at least five minutes if the patient is receiving anticoagulants. 16.Label the specimen containers, checking requisition for patient identification and requested tests. 17.Remove gloves and wash hands.

Background Sciences and Application Methods



Background Sciences and Application Methods


Formal study of CLS includes a curriculum of diverse natural and physical science courses in addition to the corps of minimum graduation requirements for a B.A. or B.S. with minor in Biology or Chemistry. Click here for a typical undergraduate curriculum for a BS degree in CLS.

In addition, registration with a professional association or licensure by many states requires a minimum 1 year internship in an accredited Medical Technology program provided at many larger hospital laboratories. Several years ago hospitals would pay a stipend to students in their programs. Most such programs now charge a tuition comparable to standard university tuition.


COMMON PROCEDURES

There are many basic procedures and methods which are common to nearly all clinical laboratories. Listed below are some common procedures (and some not so common) and their descriptions. Additional specialty methods (particularly immunological) are described here. A Glossary of Diagnostic Terminology is located here.


Optical Microscopy


Brightfield Microscopy

With a conventional bright field microscope, light from an incandescent source is aimed toward a lens beneath the stage called the condenser, through the specimen, through an objective lens, and to the eye through a second magnifying lens, the ocular or eyepiece.



Specimens that may be observed using bright-field microscopy:

Prepared slides, stained - bacteria (1000x), thick tissue sections (100x, 400x), thin sections with condensed chromosomes or specially stained organelles (1000x), large parasites (100x). Smears, stained - blood (400x, 1000x), stained bacteria (400x, 1000x). Living preparations (wet mounts, unstained) - yeast suspensions (40x, 100x, 400x), living parasites or their ova (40x, 100x, 400x ccasionally), fungal preperations (40x, 100x, 400x).

It is best to start with the lowest magnification objective lens, to home in on the specimen and/or the part of the specimen you wish to examine. It is rather easy to find and focus on sections of tissues, especially if they are fixed and stained, as with most prepared slides. However it can be very difficult to locate living, minute specimens such as bacteria or unpigmented cells.

The lowest power lens is usually 3.5 or 4x, and is used primarily for initially finding specimens. We sometimes call it the scanning lens for that reason. The most frequently used objective lens is the 10x lens, which gives a final magnification of 100x with a 10x ocular lens. For very small details in prepared slides such as cell organelles, you will need a higher magnification. Typical high magnification lenses are 40x and 97x or 100x. The latter two magnifications are used exclusively with oil in order to improve resolution.

Move up in magnification by steps. Each time you go to a higher power objective, re-focus and re-center the specimen. Higher magnification lenses must be physically closer to the specimen itself, which poses the risk of jamming the objective into the specimen. Be very cautious when focusing. Good quality sets of lenses are parfocal, that is, when you switch magnifications the specimen remains in focus or close to focused.

Adjust illumination so that the field is bright without hurting the eyes. Adjust the condenser. The condenser lense is used to focus light on the specimen through an opening in the stage. Start with the aperture diaphragm stopped down (high contrast). You should see the light that comes up through the specimen change brightness as you move the aperture diaphragm lever.

Dark Field Microscopy

To view a specimen in dark field, an opaque disc is placed underneath the condenser lens, so that only light that is scattered by objects on the slide can reach the eye. Instead of coming up through the specimen, the light is reflected by particles on the slide. Everything is visible regardless of color, usually bright white against a dark background. Pigmented objects are often seen in "false colors," that is, the reflected light is of a color different from the color of the object. Better resolution can be obtained using dark as opposed to bright field viewing.

You don't need sophisticated equipment to get a dark field effect, but you do need a higher intensity light, since you are seeing only reflected light. At low magnification (up to 100x) any decent optical instrument can be set up so that light is reflected toward the viewer rather than passing through the object directly toward the viewer.

Phase Contrast Microscopy

Most of the detail of living cells is undetectable in bright field microscopy because there is too little contrast between structures with similar transparency and no color. Unless the specimen mount is extremely thin, dark field mode may distort details. However, the various organelles show wide variation in refractive index, that is, the tendency of the materials to bend light, providing an opportunity to distinguish them.

Highly refractive structures bend light to a much greater angle than do structures of low refractive index. The same properties that cause the light to bend also delay the passage of light by a quarter of a wavelength or so. In a light microscope in bright field mode, light from highly refractive structures bends farther away from the center of the lens than light from less refractive structures and arrives about a quarter of a wavelength out of phase.

Light from most objects passes through the center of the lens as well as to the periphery. If the light from an object to the edges of the objective lens is retarded a half wavelength and the light to the center is not retarded at all, then the light rays are out of phase by a half wavelength. They cancel each other when the objective lens brings the image into focus. A reduction in brightness of the object is observed. The degree of reduction in brightness depends on the refractive index of the object.




Phase Contrast Condensers and Objective Lenses

To use phase contrast the light path must be aligned. An element in the condenser is aligned with an element in a specialized phase contrast lens. This usually involves sliding a component into the light path or rotating a condenser turret. The elements are either lined up in a fixed position or are adjusted by the observer until the phase effect is optimized. Generally, more light is needed for phase contrast than for corresponding bright field viewing, since the technique is based on a diminishment of brightness of most objects.
Schematic configuration for phase contrast microscopy: Light passing through the phase ring is first concentrated onto the specimen by the condenser. Undeviated light enters the objective and is advanced by the phase plate before interference at the rear focal plane of the objective.

Photomicrograph of hair cross sections from a fetal mouse using phase contrast microscopy (200X). 


Polarized Light Microscopy

Many transparent solids are optically isotropic, meaning that the index of refraction is equal in all directions throughout the crystalline lattice. Examples of isotropic solids are glass, sodium chloride, many polymers, and a wide variety of both organic and inorganic compounds.

Crystals are classified as being either isotropic or anisotropic depending upon their optical behavior and whether or not their crystallographic axes are equivalent. All isotropic crystals have equivalent axes that interact with light in a similar manner, regardless of the crystal orientation with respect to incident light waves. Light entering an isotropic crystal is refracted at a constant angle and passes through the crystal at a single velocity without being polarized by interaction with the electronic components of the crystalline lattice.

Anisotropic crystals have crystallographically distinct axes and interact with light in a manner that is dependent upon the orientation of the crystalline lattice with respect to incident light. When light enters non-equivalent axes, it is refracted into two rays, each polarized with their vibration directions oriented at right angles to each other and traveling at different velocities. One of the rays travels with the same velocity in every direction through the crystal and is termed the 'ordinary ray'. The other ray travels with a velicity that is dependent upon the propagation direction within the crystal and is termed the 'extraordinary ray'.

A polarizer is placed beneath the substage condenser causing polarized light to enter the anisotropic crystal where it is refracted into two separate component rays vibrating parallel to the crystallographic axes and perpendicular to each other. The polarized light waves then pass through the specimen and objective lense before reaching a second polarizer, termed the 'analyzer', that is oriented to pass a polarized vibration direction perpendicular to that of the substage polarizer.
Schematic configuration for polarized light microscopy: White light is plane polarized by the substage polarizer and concentrated onto the anisotropic specimen by the condenser. Light rays emerging from the specimen interfere when they are recombined in the analyzer, subtracting some of the wavelengths of white light and producing a myriad of colors.


Photomicrograph of high-density liquid crystalline calf thymus DNA using polarized light microscopy (100X).

Microscopy with Oil Immersion

When light passes from a material of one refractive index to material of another, as from glass to air or from air to glass, the light bends. Light of different wavelengths bends at different angles, so that as objects are magnified the images become less and less distinct. This loss of resolution becomes very apparent at magnifications of above 400x or so. Even at 400x the images of very small objects are badly distorted.

Placing a drop of oil with the same refractive index as glass between the cover slip and objective lens eliminates two refractive surfaces and considerably enhances resolution, so that magnifications of 1000x or greater can be achieved.

To use an oil immersion lens, first focus on the area of specimen to be observed with the high dry (400x) lens. Place a drop of immersion oil on the cover slip over that area, and very carefully swing the oil immersion lens into place. Focus carefully, preferably by observing the lens itself while bringing it as close to the cover slip as possible, then focusing by moving the lens away from the specimen. When in focus, the lens nearly touches the cover slip. The focal plane is so narrow that it is very easy to focus right past it. If you are focusing toward the specimen, you can drive the lens right into it.

When to Use Oil Immersion Objective Lenses

Use an oil immersion lens when you have a fixed (dead - not moving) specimen that is no thicker than a few micrometers. Even then, use it only when the structures you wish to view are quite small - one or two micrometers in dimension. Oil immersion is essential for viewing individual bacteria or details of the striations of skeletal muscle. It is nearly impossible to view living, motile microorganisms at a magnification of 1000x, except for the very smallest and slowest.

A disadvantage of oil immersion viewing is that the oil must stay in contact, and oil is viscous. A wet mount must be very secure to use oil. Oil immersion lenses are used only with oil, and oil can't be used with dry lenses, such as your 400x lens. Lenses of high magnification must be brought very close to the specimen to focus and the focal plane is very shallow, so focusing can be difficult. Oil distorts images seen with dry lenses, so once you place oil on a slide it must be cleaned off thoroughly before using the high dry lens again. Oil on non-oil lenses will distort viewing and possibly damage the coatings.

Fluorescence Microscopy

To understand how fluorescence microscopy works and why it has become so important to modern biology, one must understand what the term fluorescence means. Fluorescence is the luminescence of a substance when it is excited by radiation. In microscopy, fluorescence is used as a means of preparing specific biological probes. Some biological substances like chlorophyll and some oils and waxes have primary fluorescence; that is, they autofluoresce. But most biological molecules or structures do not fluorescence on their own, so they must be linked with fluorescent molecules (or fluorochromes) in order to create specific fluorescent probes.

Fluorescence of a substance is seen when the molecule is exposed to a specific wavelength of light (excitation wavelength or spectrum) and the light it emits (the emission wavelength or spectrum) is always of a higher wavelength. To view this fluorescence in the microscope, several light filtering components are needed. Specific filters are needed to isolate the
excitation and emission wavelengths of a fluorochrome. A bright light source with proper wavelengths for excitation is also needed. For normal fluorescence applications, this is a mercury vapor arc burner. For fluorescence confocal microscope applications where up to 95% of the emission light is filtered out, specific wavelength lasers are used as these are extremely bright. Mercury arc burners are very bright lamps with a limited lifetime and require some maintenance and care to make sure that they are producing the brightest possible light beam for fluorescence excitation.

One other component is required: a dichroic beam splitter or partial mirror which reflects lower wavelengths of light and allows higher wavelengths to pass. A beam splitter is required because the objective acts as a condenser lens for the excitation wavelength as well as the objective lens for emission. One only wishes to see the light emitted from the fluorochrome and not any of the excitation light, and the beam splitter isolates the emitted light from the excitation
ANA patterns using fluorescence microscopy
wavelength. This epi-illumination type of light path is required to create a dark background so that the fluorescence can be easily seen. The wavelength at which a beam splitter allows the higher wavelengths to pass must be set between the excitation and emission wavelengths of any given fluorochrome so that excitation light is reflected and emission light is allowed to pass through it.

Spectrophotometry


UV and Visable Spectrophotometry

Spectrophotometry is the use of an instrument called a spectrophotometer to detrmine absorption spectra of compounds, perform kinetic assays or to determine the concentration of organic or inorganic analytes in solution. The instrument may produce tunable or fixed monochromatic light of specific wavelength for absorbance measurements. The most common adaptation uses wavelengths of the visible light portion (ca. 340-900 nanometers - 1 nm=10-9 Meter) of the electromagnetic spectrum. For operation between 340-1000 nm, a tungsten filament lamp is sufficient; for operation between 180-340 nm the light source must be a Hydrogen or Deuterium lamp and the cuvette cells must be quartz glass.

Diagram of the basic components of a spectrophotometer, consisting of light source (Lamp), Prism or grating, Colimator, Cuvette (Test Cell), Detector (selenium or silicon photocell or photomultiplier tube) and Display (analog or digital). In some implementations the Lamp, Prism and Colimator are a separate unit known as a 'Monochromator'. Physical arangements and enhancements vary with specific applications.Spectronic 20 Spectrophotometer: It is manufactured in several configurations.


The Beer-Lambert Law

Within limitations, the law states that when a sample is placed in the beam of a spectrophotometer, there is a direct linear relationship between the amount (concentration) of its constituent(s) and the amount of energy it absorbs. This may be stated mathematically:

log10(I0/I)= A = elC

or rearranged,
C = A/el
where,
               I0 = incident radiation, I = transmitted radiation
               A = absorbance
               e = extinction coefficient at a given wavelength
               l = pathlength in cm.
               C = molar concentration, [M]
(The extinction coefficient, molar absorptivity, has units M-1cm-1; hence, most standard cuvette cells have a pathlength of 1 cm.)

When the molar absorptivity constant is known for a substance at a specific wavelength, the Beer equation may be used to directly determine concentration. Example: NADH (reduced nicotinamide adenine dinucleotide), a substance employed in many enzyme-catalized chemical reactions, is known to have a molar absorptivity of 6.220 mM-1cm-1 at 340 nm. Measurement of the absorption of an unknown concentration of NADH at 340 nm and application of the Beer equation will yield a quantitative measurment of NADH in solution. For example, if the absorption of an unknown NADH solution at 340 nm in a 1 cm cell is 0.622, then the concentration may be calculated from
                    Cu = 0.622/[(6.22 mM-1cm-1)(1 cm)] = 0.1 mM NADH

Of course, the utility of this measurement is predicated on the knowledge that this is a pure solution of NADH or that there are no other 340 nm-absorbing substances present.

More commonly, however, an analyte must be measured by indirect photometric methods. This circumstance arises when the molar absorptivity of a substance is unknown or when the absorbance of a substance is very low at all practical spectral wavelengths or when there are other substances present which absorb at the substance's spectral maxima.

An indirect photometric method employs a chemical reaction(s) to produce another substance which has unique absorption properties. A procedure which uses this method is the simplified Fearon analysis for urea, a waste product of protein catabolism which is produced in the liver and excreted by the kidney. While urea in solution is
In the Fearon procedure for serum urea quantitation, urea condenses with diacetyl to form diazine. Since diacetyl is unstable, diacetyl monoxime is substituted and generates the required diacetyl in the same reaction mixture. Also, thiosemicarbazide and ferric ions are added to enhance and stabalize the product.virtually transparent to all practical visible and uv wavelengths, the new product, diazine, absorbs strongly at 540 nm and its concentration is directly related to the concentration of urea.

Calibration

Calibration of a method is applied using a wide variety of mathematical methods or mathematical models. In practice, nearly all photometric methods require calibration with standard solutions of known value because of
minor variations in procedure, variations in reagent composition or deviations from Beer's law. For some methods the chemical and photometric properties are so well behaved that only a single calibration datum is required, and unknown values are calculated from the simple relation

Cu = Cs x [Au / As]


      where        Cu = Concentration of the Unknown solution
                   Cs = Concentration of the Standard solution
                   Au = Absorbance of the Unknown solution
                   As = Absorbance of the Standard solution
INFRARED SPECTROSCOPY

IR is one of numerous spectrometric techniques for analyzing the chemistry of materials. In all cases, spectrometric analysis implies a measurement of a very specific wavelength of light energy, either in terms of amount absorbed by the sample in question, or the amount emitted from the sample when suitably energized.

IR is an absorption form of spectrometric analysis. Unlike atomic absorption, IR is not concerned with specific elements (such as Lead, Copper, etc.) but, rather, with the groupings of atoms in specific combinations to form what are called "functional groups". These various functional groups help to determine a material's properties or expected behavior.

By knowing which wavelengths are absorbed by each functional group of interest one can cause the appropriate wavelength to be directed at the sample
being analyzed, then measure the amount of energy absorbed by the sample. The more energy absorbed, the more of that particular functional group exists in the sample; therefore, results can be numerically quantified. The units of measurement are usually expressed as Absorbance Units.

FOURIER TRANSFORM INFRARED SPECTROSCOPY

Fourier transform infrared (FTIR) spectroscopy is a powerful analytical tool for characterizing and identifying organic molecules. The IR spectrum of an organic compound serves as its fingerprint and provides specific information about chemical bonding and molecular structure.

Microbeam FTIR allows areas as small as 10-15 microns to be analyzed; this allows the source of organic particles to be determined. Using attenuated total reflectance (ATR), thin films can be analyzed directly on a surface. SSL uses FTIR to aid in precise determination of the chemical identity of organic contamination in a variety of samples including samples from the disk drive, biomedical, semiconductor, PCB, electronic, laser and optic industries.

ADVANTAGES OF FTIR:

           Small spot size (10-15 microns) 
           Detailed chemical bonding information 
           Organic analysis of polymers and plastics 
           Analysis of liquids, solids, and gases 
           In ATR mode can sample the outer ~ 1000  
           Non-destructive analysis 
           Can analyze non-conductive materials 
           Molecular specific identification 

RAMAN SPECTROSCOPY

Raman spectroscopy is based on the inelastic scattering of light by a molecule, and is a type of spectroscopy that is complementary to infrared spectroscopy. There are two common methods for measuring vibrational spectra. Infrared spectroscopy is a direct method which looks at the transition between vibrational levels in a single electronic state. IR transitions range from < 200 cm-1 to >4000 cm-1.

IR spectroscopy can be a useful tool for identifying molecules; however, its usefulness is limited by several factors:
1) A molecule must have a change in its dipole moment upon absorption if the absorption is to take place. Thus, molecules such as homonuclear diatomics are IR inactive. 2) In general, transitions between a vibrational level and the next higher vibrational level (v -> v+1) are strong.

Some of these problems are reduced in Raman spectroscopy. This type of spectroscopy is based on light scattering. If light of a particular wavelength is aimed at a sample, much of the light will pass through, but some will be scattered in all directions. Of that scattered light, most comes out at the same wavelength it went in: no energy is exchanged between the light and the molecule. This is elastic or Rayleigh scattering. But some light will lose energy to the molecule; however, it can only lose an amount of energy that is the same as one of the vibrational transitions in the molecule. Therefore, the scattered light has less energy (a longer wavelength) than the incoming light. This is inelastic or Raman scattering. In order to see the Raman scattering, one must detect away from where the incident light shines through. The detector includes a monochromator which allows us to determine the spectrum of the scattered light.

Raman and IR spectroscopy are complementary and overlapping techniques for understanding molecular rotations and vibrations. A large IR absorption requires a large change in the electric dipole moment of the molecule [mij =  yi x yj dv >> 0]. A large Raman signal requires a large change in the polarizability of the molecule [aij =  yi ayj dv >>0 ]. While many transitions have both large mij and large aij, there are many that don't. Therefore, Raman and IR can act together to give a more complete description of the molecule.


Chromatography


Chromatography is a separation process involving two phases, one stationary and the other mobile. Typically, the stationary phase is a porous solid (e.g., glass, silica, or alumina) that is packed into a glass or metal tube or that constitutes the walls of an open-tube capillary. The mobile phase flows through the packed bed or column. The sample to be separated is injected at the beginning of the column and is transported through the system by the mobile phase. In their travel through the column, the different substances distribute themselves according to their relative affinity for the two phases. The rate of travel is dependent on the values of the distribution coefficients, the components interacting more strongly with the stationary phase requiring longer time periods for elution (complete removal from the column). Thus, separation is based on differences in distribution behaviour reflected in different migration times through the column. At the present time, chromatography is the most significant method for separation of organic substances and, along with electrophoresis, is most widely used for biological substances.

The various chromatographic methods are characterized in terms of the mobile phase--gas: gas chromatography (GC); liquid: liquid chromatography (LC); supercritical fluid: supercritical-fluid chromatography (SFC). The methods are then further subdivided in terms of the stationary phase; thus, if the stationary phase is a solid adsorbent, there are methods such as gas-solid chromatography (GSC) and liquid-solid chromatography (LSC). Chromatography is conducted with computer-controlled instrumentation for high precision and unattended operation. In addition, a detector is frequently placed on-line after the column for either structure analysis or quantitation or both. One of the most powerful approaches of analysis now available is the on-line coupling of chromatography to mass spectrometry.

In Gas Chromatography, the determining factor in how fast a component travels is usually (but not always) the boiling point of the compound. (If a polar high-boiling liquid adsorbent is used in the GC column, the polarity of the components determines the elution order.)Gas chromatography is an important method owing to its speed, resolving power, and detector sensitivity. Since it depends on vaporization, this technique is best suited to compounds that can be vaporized without suffering decomposition. Many substances that normally do not easily vaporize can be chemically derivatized for successful volatilization separation by gas chromatography.

Right-click and click Reload to view the animation at left.


Since the early 1970s, liquid chromatography has developed as the premier separation method for organic substances. Because the mobile phase is a liquid, the requirement for vaporization is eliminated, and therefore LC can separate a much broader range of substances than GC. Species that have been successfully resolved include inorganic ions, amino acids, drugs, sugars, oligonucleotides, and proteins. Both analytical-scale liquid chromatography with samples at the microgram-to-milligram level and preparative-scale liquid chromatography at the tens-of-grams level have been developed. In biotechnology, preparative-scale liquid chromatography is especially important for purification of proteins and peptide hormones made by recombinant technology.

One important method is liquid-solid chromatography in which the porous adsorbent is polar, and separation is based on the properties of classes of compounds--e.g., amines (alkaline) from alcohols (neutral) and esters (neutral) from acids. Liquid-solid chromatography is the oldest of the chromatographic methods. Until the mid-20th century, the experimental procedure had not changed much from its original form. After significant improvements, liquid-solid chromatography now is conducted with porous particles as small as 3-5 micrometres (0.00012-0.00020 inch) in diameter, and liquid pumps are used to drive the liquid through the particle-filled column. High resolution and fast separations are achieved since the small particles allow good efficiency with fast mobile phase velocities (one centimetre per second or higher). This technique is also important in purification, and separated substances can be automatically collected after the column using a fraction collector.

A significant liquid-solid chromatography procedure is reverse-phase chromatography, in which the liquid mobile phase is water combined with an organic solvent such as methanol or acetonitrile and the stationary phase surface is nonpolar or hydrocarbon-like. In contrast to normal-phase chromatography, where the adsorbent surface is polar, in reverse-phase chromatography the elution of substances from the column is in the order of increasing polarity. In addition, separation is based on the nonpolar aspects of the substances. In the separation of a series of peptides from human growth hormone, a recombinantly made drug, an enzyme, trypsin, is used to break peptide bonds containing the basic amino acids--arganine and lysine--to yield a specific fingerprint of the protein. Peptide mapping is a critical method for evaluating the purity of complex substances such as proteins.

Ion-exchange chromatography (IEC) is a subdivision of liquid-solid chromatography, but its importance is such that it deserves special mention. As the name implies, the process separates ions; the basis of the separation is the varying attraction of different ions in a solution to oppositely charged sites on a finely divided, insoluble substance (the ion exchanger, usually a synthetic resin). In a cation-exchange resin all the sites are negatively charged, so that only positive ions can be separated; an anion-exchange resin has positively charged sites. Ion-exchange chromatography has become one of the most important methods for separating proteins and small oligonucleotides. An important application of ion exchange is the removal of dissolved iron, calcium, and magnesium ions from hard water. The negative sites on a cation exchanger are first neutralized with sodium ions by exposure to a strong solution of common salt (sodium chloride); when the hard water is passed through the resin, the undesirable ions in the water are replaced by sodium ions.

Liquid-solid adsorption chromatography also can be performed on thin, flat plates (thin-layer chromatography, or TLC). TLC is inexpensive and rapid but not as sensitive or efficient as column chromatography. In practice, the adsorbent is spread on a glass plate and dried. The sample is applied as a spot near one end of the plate, which is placed (vertically) in a shallow reservoir containing the mobile phase. As the mobile phase travels up the plate by capillary action, the sample dissolves in the liquid, and its components are transported up the plate to new positions at varying distances from the starting point.

Separation of chemical components of a mixture is achieved due to the selective interaction of chemicals with both the stationary and mobile phases:

In Gas Chromatography, the determining factor in how fast a component travels is usually (but not always) the boiling point of the compound. (If a polar high-boiling liquid adsorbent is used in the GC column, the polarity of the components determines the elution order.)

In Column and Thin Layer chromatographies, the stationary phase (the adsorbent: silica gel or alumina) is polar, and the polarities of both the component of the mixture and the solvent used as the mobile phase are the determining factors in how fast the compound travels.

Column chromatography is used to separate and purify components of a mixture. TLC and GC are usually (but not always!) used only to analyze mixtures: to determine the number of components and to see if a desired component is present. TLC is often used to determine the "ideal system" for a column chromatography procedure.

Determining solvent systems for TLC and Column Chromatography

When you need to determine the best system (a "system" means the eluting solvent, itself often a mixture of solvents) to develop a TLC plate or chromatography column loaded with an unknown mixture, vary the polarity of the solvent in several trial runs -- a process of trial and error. Carefully observe and record the results of the chromatography in each solvent system. You will find that as you increase the polarity of the solvent system, all the components of the mixture move faster (and visa versa with lowering the polarity). The ideal solvent system is simply: the system that separates the components.

TLC elution patterns usually extrapolate to column chromatography elution patterns. Since TLC is a much faster procedure than column chromatography, TLC is often used to determine the best solvent system for column chromatography. For instance, in determining the solvent system for a flash chromatography procedure, the ideal system is the one that moves the desired component of the mixture to a TLC Rf of 0.25-0.35 and will separate this component from its nearest neighbor by difference in TLC Rf values of at least 0.20. Therefore a mixture is analyzed by TLC to determine the ideal solvent(s) for a flash chromatography procedure.

Beginners often do not know where to start: What solvents should they pull off the shelf to use to elute a TLC plate? Because of toxicity, cost, and flammability concerns, the common solvents are hexanes (or petroleum ethers, ligroin) and ethyl acetate (an ester). Diethyl ether can be used, but it is very flammable and volatile. Alcohols (methanol, ethanol) can be used. Acetic acid (a carboxylic acid) can be used, usually as a small percentage component of the system, since it is corrosive, non-volatile, very polar, and has irritating vapors. Acetone (a ketone) can be used. Methylene chloride (halogenated hydrocarbon) is a good solvent, but it is toxic and should be avoided whenever possible. If two solvents are equal in performance and toxicity, the more volatile solvent is preferred in column chromatography because it will be easier to remove from the desired compound after isolation from a column chromatography procedure. Mix a non-polar solvent (hexanes, a mixture of 6-carbon alkanes) with a polar solvent (ethyl acetate or acetone) in varying percent combinations to make solvent systems of greater and lesser polarity.

Coupling Gas Chromatography to Mass Spectrometry

The suite of gas chromatographic detectors includes (roughly in order from most common to the least): the flame ionization detector (FID), thermal conductivity detector (TCD or hot wire detector), electron capture detector (ECD), photoionization detector (PID), flame photometric detector (FPD), thermionic detector, and a few more unusual or VERY expensive choices like the atomic emission detector (AED) and the ozone- or fluorine-induced chemiluminescence detectors. All of these except the AED produce an electrical signal that varies with the amount of analyte exiting the chromatographic column. The AED does that AND yields the emission spectrum of selected elements in the analytes as well. Another GC detector that is also very expensive but very powerful is a scaled down version of the mass spectrometer. When coupled to a GC the detection system itself is often referred to as the mass selective detector or more simply the mass detector. This powerful analytical technique belongs to the class of hybrid analytical instrumentation (since each part had a different beginning and can exist independently) and is called gas chromatograhy/mass spectrometry (GC/MS).

Placed at the end of a chromatographic column in a manner similar to the other GC detectors, the mass detector is more complicated than, for instance, the FID because of the mass spectrometer's complex requirements for the process of creation, separation, and detection of gas phase ions. A capillary column is most often used in the chromatograph because the entire MS process must be carried out at very low pressures (~10-5 torr), and in order to meet this requirement, a vacuum is maintained via constant pumping using a vacuum pump. It is difficult for packed GC columns to be interfaced to an MS detector because they have carrier gas flow rates that cannot be as successfully pumped away by normal vacuum pumps; however, capillary columns' carrier flow is 25 or 30 times less and therefore easier to "pump down." That said, GC/MS interfaces have been developed for packed column systems that allow for analyte molecules to be dynamically extracted from the carrier gas stream at the end of a packed column and thereby selectively sucked into the MS for analysis. For one type interface, using a silicone membrane, the selectivity for organic molecules (the analyte) over helium (the carrier gas) is 50,000.

The high cost for the pump, ionization source, mass filter or separator, ion detector, and computer instrumentation and software has limited the wide application of this system as compared to the less expensive GC detectors (e.g., FID cost ~$3000 vs. MS cost ~$40,000). However, the power of this technique lies in the production of mass spectra from each of the analytes detected instead of merely an electronic signal that varies with the amount of analyte. These data can be used to determine the identity as well as the quantity of unknown chromatographic components with an assuredness simply unavailable by other techniques.

Components of the GC/MS

Leaving the entire capillary GC system aside, the major components of the mass selective detector itself are: an ionization source, mass separator, and ion detector. There are two common mass analyzers or separators commercially available for GC/MS; they are the quadrapole and the ion trap.

Right-click and click Reload to view the animation at right. In this example, the lightest fragment is B+; the heaviest A+. The last frame of the movie is a mass spectrum displaying only these three fragments. Their relative mass to charge ratios are specified by their relative position on the x axis (low mass/charge to left, high mass/charge to right). The relative amounts (commonly called peak intensity) of each of these fragments determined during the mass analyzer's scan is reflected on the y axis.

GC/MS is a reference method used in the clinical laboratory to detect, identify and quantitate DAU (Drugs of AbUse) and by forensic toxicology laboratories. Click here for example IR and Mass spectra (Cocaine).
The GIF animation is a short series of steps for the process of a single analyte (already separated from the other analytes in the chromatographic mixture) denoted as ABC exiting the chromatographic column and: the analyte (A-B-C) undergoing ionization and fragmentation; the charged fragments (A+ B+ C+) being separated by mass; the fragments which are focused on the mass filter's exit slit passing into the detector; and the charged ions being detected.


Flow Cytometry


Flow cytometry is a method for quantitating components or structural features of cells primarily by optical means. Although it makes measurements on one cell at a time, it can process thousands of cells in a few seconds. Since different cell types can be distinquished by quantitating structural features, flow cytometry can be used to count cells of different types in a mixture.

Flow cytometers have been commercially available since the early 1970's, and their use has been increasing since then. The most numerous flow cytometers are those used for complete blood cell counts in clinical laboratories -- these do not employ fluorescence. More versatile research instruments employ fluorescence, hence may be distinguished as flow cytofluorometers.


< Screen print of Coulter MAXM hemogram. Cell types are classified by size, volume and internal structure.

Flow cytofluorometers are found in all major biological research institutions. They are also numerous in medical centers, where they are used for diagnosis as well as research. There are about 7,000 flow cytofluorometers in use worldwide. Ploidy and cell cycle analysis of cancers is the major diagnostic use. Lymphomas and leukemias are intensively studied for surface markers of diagnostic and prognostic value. Although less expensive alternative technologies are under development, until the present time, flow cytometry has been the method of choice for monitoring CD4 lymphocyte levels in the blood of AIDS patients.

The term "FACS" is Becton-Dickinson's registered trademark and is an acronym for Fluorescence-Activated Cell Sorter. Another major vendor of flow cytometers is Coulter Electronics.

The cells may be alive or fixed at the time of measurement, but must be in monodisperse (single cell) suspension. They are passed single-file through a laser beam by continuous flow of a fine stream of the suspension. Each cell scatters some of the laser light, and also emits fluorescent light excited by the laser. The cytometer typically measures several parameters simultaneously for each cell:

     low angle forward scatter intensity, approximately proportional to cell diameter 
     orthogonal (90 degree) scatter intensity, approximately proportional to the quantity
       of granular structures within the cell 
     fluorescence intensities at several wavelengths 
Light scatter alone is often quite useful. It is commonly used to exclude dead cells, cell aggregates, and cell debris from the fluorescence data. It is sufficient to distinguish lymphocytes from monocytes from granulocytes in blood leukocyte samples.

Fluorescence intensities are typically measured at several different wavelengths simultaneously for each cell. Fluorescent probes are used to report the quantities of specific components of the cells. Fluorescent antibodies are often used to report the densities of specific surface receptors, and thus to distinguish subpopulations of differentiated cell types, including cells expressing a transgene. By making them fluorescent, the binding of viruses or hormones to surface receptors can be measured. Intracellular components can also be reported by fluorescent probes, including total DNA/cell (allowing cell cycle analysis), newly synthesized DNA, specific nucleotide sequences in DNA or mRNA, filamentous actin, and any structure for which an antibody is available. Flow cytometry can also monitor rapid changes in intracellular free calcium, membrane potential, pH, or free fatty acids.

Flow cytometers involve sophisticated fluidics, laser optics, electronic detectors, analog to digital converters, and computers. The optics deliver laser light focused to a beam a few cell diameters across. The fluidics hydrodynamically focus the cell stream to and within an uncertainty of a small fraction of a cell diameter, and, in sorters, break the stream into uniform-sized droplets to separate individual cells. The electronics quantitate the faint flashes of scattered and fluorescent light, and, under computer control, electrically charge droplets containing cells of interest so that they can be deflected into a separate test tube or culture wells. The computer records data for thousands of cells per sample, and displays the data graphically.

Analysis Equipment: the FACScan

The Becton-Dickinson FACScan is used for analysis of cell samples. Unlike the sorter (see below), this instrument cannot separate cells into different containers based on their properties; the samples are consumed and discarded during analysis. The FACScan is a closed fluidic system, so use with biohazardous samples (such as human blood samples) is possible with appropriate precautions.

The FACScan is easy to use, and the instrument is operated by the experimenter her/himself. The FACScan uses an air-cooled argon gas laser, 15 mW output, with a fixed wavelength emission of 488 nm. It has three fluorescence detection channels which simultaneously detect green, yellow-orange, and red light. Fluorescein is used extensively for the green channel, and phycoerythrin or propidium iodide (a DNA stain) for the yellow-orange channel. Dyes are also available which can be excited at 488 nm yet emit in the red.

The FACScan can analyze cell suspensions at the rate of several hundred cells per second. Typically, investigators acquire 5,000 to 15,000 cells per sample. Data are saved to the hard disk of a dedicated Hewlett-Packard computer, where they can later be analyzed with graphics software. Data can also be transferred to a network server computer so that they are accessible from any computer network. Excellent public domain software is available for PC's which may be copied freely to any computer for data analysis.

Sorting Equipment: the FACStar Plus

A Becton-Dickinson FACStar Plus is used for cell sorting, and for analysis requirements which cannot be met on the FACScan. This instrument has a class IV water-cooled argon gas laser with a rated output in all-wavelength mode of 4 watts. This laser can be tuned, so the FACStar is used, for example, when the analysis requires excitation at 514 nm in addition to 488 nm.

The FACStar Plus can sort cells, or acquire data, at a rate of several thousand per second (about 10-fold faster than the FACScan analyzer). Because the FACStar uses a stream-in-air sorting method, it aerosolizes the sample and cannot be used for biohazardous samples. Nonhazardous living cells can be sorted, and may be recovered in gnotobiotic ("sterile") form for subsequent in vitro functional studies.

Electrochemical Measurements



Enzymology


Enzyme Structure

Enzymes are extraordinarily efficient and selective biological catalysts that accelerate the chemical reaction toward equilibrium. Chemical reactions in the metabolic pathways necessary for the maintenance of life would not proceed at reasonable rates without enzymes. Enzymatic reactions are 103to 1017 times faster than the corresponding uncatalyzed reactions.
Enzymes are globular protein molecules (M.Wt. typically 104 - 105 ) that catalyze the myriad of biochemical reactions that occur within living cells. Like their chemical counterparts, enzymes accelerate the rate of chemical reactions without themselves being changed in the overall process. A fundamental difference between enzymes and industrial catalysts however is that enzymes function at physiological temperatures in a low ionic strength solution at near neutral pH. There are many different kinds on enzyme, each promoting only a very limited range of chemical reactions. Enzymes are very efficient catalysts. One molecule of catalase for example can decompose 40,000 molecules of hydrogen peroxide per second at freezing point.
The table below gives turnover numbers for some other enzymes at room temperature.  
  
                       Enzyme                             Turnover number
                                                         (molecules/second)
                Carbonic anhydrase                            600,000
                Acetylcholinesterase                           25,000
                amylase                                        18,000
                Penicillinase                                   2,000
                DNA polymerase                                     15
The substrate molecules are bound in a hydrophobic cleft know as the active site. Enzymes whose activity is regulated generally have a more complex structure than unregulated enzymes. Most regulatory enzymes have two sites - one for the substrate, and the other for the modulator.
Enzyme Kinetics
An important feature of enzymes is that they possess specific 3-D configurations that are fundamental to their biological function. This is because the overall shape of the molecule stabilizes the precise geometric structure of the active site, the region in the enzyme where the substrate is converted into the product. The importance of the active site (which normally makes up only a small percentage of the entire molecule) is to stabilize the transition state between the substrate and its products thus lowering the activation energy for the reaction. (Lowering this energy by about 34 kJ mol-1 is calculated as bringing a million fold increase in the rate of a reaction at 298 K.) For this to occur the substrate must fit precisely into the active site (shape recognition). Indeed, the "lock and key" analogy is often used to describe substrate binding, as substrate fits an enzyme like a key fits a lock. The activation energy for the enzyme catalyzed reaction can be determined in the normal way by the Arrhenius equation;

k = Ze-Ea/RT
where k is the rate constant, Ze is a factor accounting for the frequency of collisions, R is the Gas constant, T is the absolute temperature and Ea is the activation energy. The activation energy may be determined by measurement of the reaction rate at different temperatures (limited to the thermal stability range of the enzyme) and plotting ln(k) against 1/T.
Each enzyme requires certain definite conditions for optimum performance, particularly as regards to pH, temperature and ionic strength. The presence of specific accessory substances (co-factors, activators etc.) may also be a requirement.
Enzymes are unstable substances, and are easily inactivated by high temperature or extremes of pH. Although they are not consumed during the biochemical reaction, enzymes are inherently labile and have to be continuously synthesized.
For many enzyme reactions the rate (V or dp/dt) varies with the substrate concentration [S] as shown below. The rate (V or dp/dt) is defined as the number of moles per second which is a measure of enzyme activity. At low substrate concentration the rate or velocity (V) is almost proportional to substrate[S] concentration. At high substrate [S] concentrations, the velocity is not linear with the [S] concentration and rate approaches a maximum velocity called Vmax.
The following model was proposed by Michaelis and Menten in 1913 to explain the kinetics of an enzyme reaction (equation 1). One of first great advances in biochemistry was the discovery that an enzyme transiently binds to a substrate to form a enzyme-substrate complex [ES]. The substrate binds noncovalently to the active site of the enzyme. The rate of an enzymatic reaction depends on the concentrations of both the substrate and the catalyst (enzyme). When the amount of enzyme is much less than the amount of substrate, the reaction is pseudo first order. The straight line illustrates the effect of enzyme concentration on reaction velocity in pseudo first-order reaction. The more enzyme present, the faster the reaction.

Pseudo first-order conditions are used in analyses that determine the concentration of an enzyme in a sample. The concentration of enzyme can be easily determined by comparing its activity to a reference curve as shown at left.Modern automated clinical chemistry analyzers store the kinetic reaction constants in their computer and calculate unknown values from measured absorbance changes over standard time. This implementation of enzyme measurement is known as a kinetic method. In fact, most analyses (not merely for enzymes) employ a kinetic method - because they are faster. End-point methods often require up to an hour or more for the reaction to achieve equilibrium, whereas kinetic methods may require just a few minutes.

At the beginning of an enzyme-catalyzed reaction, the amount of product formed is negligible, and the reaction can be described by equation 1. Note that the conversion of the ES complex into free enzyme and product is shown by a one-way arrow. During the initial period when measurements are made little product has been formed, so the rate of the reverse reaction is small. The velocity measured during this short period is called the initial velocity (vo). The use of initial velocity simplifies the interpretation of kinetic data and avoids complications that may arise as the reaction progresses, such as product inhibition, depletion of substrate, and slow denaturation of the enzyme.


Equation 1:

An enzyme (E) combines with [S] to form an ES complex, with a rate constant k1. The ES complex has two possible fates. It can dissociate to form E and S, with a rate constant k2, or it can proceed to form product P, with a rate constant k3 (kcat). It is assumed that almost none of the product reverts to the initial substrate. The velocity of the reaction is then V (dp/dt) is represented by equation 2.
Equation 2:

dp/dt=kcat[ES] or V= kcat[ES]
Expressing [ES] in terms of known quantities, the rates of formation and breakdown of ES are given by:
Equation 3:

Rate of formation of ES = k1[E][S]
Equation 4:

Rate of breakdown of ES = (k2[ES] + kcat[ES]) =k2 + kcat[ES]
We are interested in the catalytic rate under steady-state conditions. With steady-state the concentration of the intermediate [ES] stays the same while the concentrations of the starting material and product are changing. Equation 5 represents steady-state conditions.
Equation 5:

k1[E][S] = (k2 + kcat)[ES]
Rearranging equation 5,

The maximal rate, Vmax, is attained when the enzyme sites are saturated with substrate. The maximal velocity is when [S] is much greater than the value of Km so that [S]/([S] + Km) approaches 1 as shown in equation 6. Thus,
Equation 6:

Vmax=kcat[ET]

The Michaelis-Menten equation accounts for the kinetic data given in Figure 1. At very low substrate concentration, when [S] is much less than Kmthen the velocity is as shown in equation 7:
Equation 7:

V=[S]Vmax /Km
In equation 7 the velocity is directly proportional to the substrate concentration. At high substrate concentration, when [S] is much greater than K m, the velocity (V) is the maximal rate (Vmax), and independent of the substrate concentration which depends on the total enzyme concentration, E, and rate constant k3 as shown by this in equation 6.
The meaning of Km is evident from the Michaelis-Menten equation. When [S] = Km, then V=Vmax/2. Thus, Km is equal to the substrate concentration at which the reaction rate is half of its maximal value.
The Michaelis constant, Km, and the maximal rate, Vmax, can be readily derived from rates of catalysis measured at different substrate concentrations if an enzyme operates according to the simple scheme given in the Michaelis Menten equation. It is convenient to transform the Michaelis-Menten equation into one that gives a straight line plot. This can be done by taking the reciprocal of both sides of the equation.
A plot of 1/V versus 1/[S], called a Lineweaver-Burk plot, yields a straight line with and intercept of 1/Vmaxand slope of Km/Vmax
Figure 2.

Table 1: Rate equation data

[S] Molarity

V   DP/min.

1/[S]

1/V

0.002

0.045

500

22.2

0.005

0.115

200

8.6

0.02

0.285

50

3.5

0.04

0.38

25

2.6

0.06

0.46

16.6

2.2

0.08

0.497

12.5

2.0

0.1

0.505

10

1.9

0.12

0.51

8.3

1.9

0.14

0.515

7.14

1.9

0.16

0.517

6.25

1.9


Figure 1: The plot is the reaction velocity V verses the concentration of the substrate [S]. The maximum velocity Vmax is the velocity where the enzyme is saturated with substrate[S] and 1/2 Vmax is that substrate [S] where the velocity 1/2 Vmax.
The Michaelis constant, Km, and the maximal rate, Vmax can be readily derived from rates of enzyme catalyzed reaction measured at different substrate concentrations. The enzyme must operate according to the simple scheme given in equation 1.
It is convenient to transform the Michaelis-Menten equation into one that gives a straight line plot. This can be done by taking the reciprocal of both sides of the equation. A double-reciprocal plot of enzyme kinetics: 1/V is plotted as a function of 1/[S]. The slope is Km/Vmax, the intercept on the vertical axis is 1/Vmax, and the intercept on the horizontal axis is -1/Km.
Km and Vmax for an enzyme-catalyzed reaction can be measured in several ways. Both values can be obtained by analysis of initial velocities at a series of substrate concentrations and a fixed concentration for the enzyme. In order to obtain reliable values for the kinetic constants, the [S] point must be spread out both below and above Km to produce a hyperbola. It is difficult to determine either Km or Vmax directly from a graph of initial velocity versus concentration because the curve approaches Vmax asymptotically. However, using a suitable computer program, accurate values can be determined by fitting the experimental results to the equation for the hyperbola.
The Michaelis-Menten equation can be rewritten in order to obtain values for Vmax and Km from straight lines on graphs. The most commonly used transformation is the double-reciprocal Lineweaver-Burk plot. Values of Km can be determined even when enzymes have not been purified, provided that only one enzyme in the impure preparation can catalyze the observed reaction.
Table 2 Km values of some enzyme
EnzymeSubstrate Km (mM) 
ChymotrypsinAcetyl-L-tryptophanamide 5,000
LysozymeHexa-N-acetylglucosamine 6
b-GalactosidaseLactose4,000
Threonine deaminaseThreonine 5,000
Carbonic anhydraseCO2800
PenicillianaseBenzylpenicillin 50
Pyruvate CarboxylasePyruvate HCO3-
ATP 
400 1,000
50
Arginine-tRNA synthetaseArginine tRNA
ATP 
3 0.4
300

At high substrate concentration, when [S] is much greater than Km, V=Vmax, i.e., the rate is maximal, independent of substrate concentration. When V=Vmax then [S]/([S] + Km) approaches 1. When [S] = Km then V = Vmax/2. Thus Km is equal to the substrate concentration at which the reaction rate is half of its maximal value. When the [S] is less than Km then the V=Vmax [S]/Km and the substrate concentration is proportional to the velocity.
The significance of Km and Vmax values
The K m values of enzymes range widely (0.4 µM for Arginine-tRNA synthetase to 5,000 µM for chymotrypsin). For most enzymes Km lies between 10-1 and 10-7 M. The Km value for am enzyme depends on the particular substrate and also on environmental conditions such as pH, temperature, and ionic strength. The Michaelis constant, Km has two meanings. First, Km is the concentration of substrate at which half the active sites are filled. Once the Km is known, the fraction of site filled at any substrate concentration can be calculated from the equation

If you divide the velocity by maximal velocity then you get the number of sites filled fES =V/Vmax or if you use this equation fES = [S]/([S] + Km) then you get the fraction of site filled
Second K m is related to the rate constants of the individual steps in the catalytic scheme given in the following equation.
Km=(k2 + kcat)/k1
Equation 1:

Consider a limiting case in which k2 is much greater than kcat. This means that the dissociation of the ES complex to E and S is much more rapid than formation of E and Product. Under these conditions (k2 >>kcat) and Km equals.
K m =k2 /k1
The dissociation constant of the ES complex is given by
K ES =[E][S]/[ES]=k2 /k1
In other words, Km is equal to the dissociation constant of the ES complex if kcat is much smaller than k2. When this condition is met. Km is a measure of the strength of the ES complex: A high Km indicates weak binding ; a low Km indicates strong binding. It must be stressed that Kmindicates the affinity of the ES complex only when k2 is much greater than kcat.
Turnover number
The turnover number of an enzyme is the number of substrate molecules converted into product by an enzyme molecule in a unit of time when the enzyme is fully saturated with substrate. It is equal to the kinetic constant kcat. The maximal rate Vmax, reveals the turnover number of an enzyme if the concentration of active site [ET] is known, because
V max =kcat [ET]
For example, a 10-6 M solution of carbonic anhydrase catalyzes the formation of 0.6 M H2CO3 per second when it is fully saturated with substrate. Hence, kcat is 6 X 105 s-1.
kcat= Vmax/Et = 0.6/10-6=6 X 10S-1
This turnover number is one of the largest known. Each round of catalysis occurs in a time equal to 1/kcat, which is 1.7 microseconds for carbonic anhydrase. The turnover numbers of most enzymes with their physiological substrates fall in the range from 10 to 107 per second.
  • Examples of catalytic constants
  • EnzymeKcat(s-1)
    Papain10
    Ribonuclease100
    Carboxypeptidase100
    Trypsin100 to 1,000
    Acetylcholinesterase1,000
    Kinases1,000
    Dehydrogenases1,000
    Transaminases1,000
    Carbonic anhydrase1,000,000
    Superoixe dismutase1,000,000
    catalase10,000,000

     Kinetic Perfection in Enzymatic Catalysis (The K cat /K m)
    When the substrate concentration is much greater than Km, the rate of catalysis is equal to k cat, the turnover number, as described in the preceding section. However, most enzymes are not normally saturated with substrate. Under physiological conditions, the [S]/Km ratio is typically between 0.01 and 1.0. when [S]<<Km, the enzymatic rate is much less than kcat because most of the active sites are unoccupied. Is there a number that characterizes the kinetic of an enzyme under these conditions? Indeed there is, as can be shown by combining two equations.

    When [S]<<Km, the concentration of free enzyme, [E], is nearly equal to the total concentration of enzyme [ET], and so
    V=kcat/Km([S][ET]
    Thus, when [S} <<Km, the enzymatic velocity depends on the value of Kcat/Km and on [S]. Are there any physical limits on the value of kcat/Km? Note that this ratio depends on k1, k2, and kcat, as can be shown by substituting for Km:
    kcat/Km=kcatk1/k2+kcat <k1
    Thus the ultimate limit on the value of kcat/Km is set by k1, the rate of formation of the ES complex. This rate cannot be faster than the diffusion-controlled encounter of an enzyme and its substrate. Diffusion limits the value of k1 so that it cannot be higher than between 10and 109 M-1S-1. Hence, the upper limit on kcat/Km is between 108 and 10M-1S-1.
    This restriction also pertains to enzymes having more complex reaction pathways. Their maximal catalytic rate when substrate is saturating, denoted by kcat, depends on several rate constants rather than on kcat alone. The pertinent parameter for these enzymes is kcat/Km. In fact, the kcat/Km ratios of the enzymes acetycholinesterase, carbonic anhydrase, and trisephophate isomerase are between 10and 109 M-1 S-1, which shows that they have attained kinetic perfection. Their catalytic velocity is restricted only by the rate at which they encounter substrate in the solution. Any further gain in catalytic rate can come only by decreasing the time for diffusion. Indeed, some series of enzymes are associated into organized assemblies so that the product of one enzyme is very rapidly found by the next enzyme. In effect, products are channeled from one enzyme to the next, much as in an assembly line.
    The constants kcat and kcat.Km are useful for comparing the activities of different enzymes. It is also possible to assess the efficiency of an enzyme by measuring the rate acceleration that it provides. This value is the ratio of the rate constant for a reaction in the presence of the enzyme (kcat) divided by the rate constant for the same reaction in the absence of enzyme(kn). Surprisingly few rate acceleration values are known because most cellular reactions occur extremely slowly in the absence of enzymes.
    Competitive and Noncompetitive Inhibition
    Measurements of the rates of catalysis at different concentrations of substrate and inhibitor serve to distinguish between competitive, uncompetitive and noncompetitive inhibition. An inhibitor (I) is a compound that binds to an enzyme and interferes with its activity by preventing either the formation of the ES complex or its breakdown to E +P. Inhibitors are used experimentally to investigate enzyme mechanisms and to decipher metabolic pathways. Natural inhibitors regulate metabolism, and many drugs are enzyme inhibitors. Inhibition can be either irreversible or reversible. Irreversible inhibitors are bound to enzymes by covalent bonds. Reversible inhibitors are bound to enzymes by the same noncovalent forces that bind substrates and products.
    The constant for the dissociation of I from the EI complex, called the inhibition constant (Ki), is described by the equation Ki =[E][I]/[EI]
    Effects of Reversible Inhibitors on Kinetic Constants
    Type of inhibitorEffect
    Competitive (I bind to E only)Raises Km and Vmax remains unchanged
    Uncompetitive (I binds to ES onlyLowers Vmax and Km Ratio of Vmax.KmRemains unchanged
    Noncompetitive (I binds to E or ES)Lowers Vmax Km remains unchanged


    Competitive Inhibition
    When a nonmetabolizable molecule, I, resembles a metabolizable molecule, S, sufficiently to be bound to the enzyme, then I remains attached to the enzyme and prevents the attachment of S, thus competing with S for space on the enzyme surface. The inhibition of the reactions of S is called classical competitive inhibition. Nonclassical competitive inhibition is the binding of S at the active site and prevents the binding of I at a different site. The reverse is also true.

    For example, malonic acid resembles succinic acid because both have two carboxyl groups. Malonic acid inhibits the action of succinic dehydrogenase on succinic acid by clogging the active site on the enzyme, and since malonic acid and succinic dehydrogenase does dissociate at a finite rate given by the dissociation constant. Therefore, an excess of succinic acid will reverse the action of malonic acid.

    Malonic Inhibition

     Ethanol is Used Therapeutically as a Competitive Inhibitor to Treat Ethylene Glycol Poisoning.
    About fifty deaths occur annually from the ingestion of ethylene glycol, a constituent of antifreeze. Ethylene glycol itself is not lethally toxic. Rather, the harm is done by oxalic acid, the oxidation product of ethylene glycol, because the kidneys are severely damaged by the deposition of oxalate crystals. The first committed step in this conversion is the oxidation of ethylene glycol to an aldehyde by alcohol dehydrogenase. This reaction can be effectively inhibited by administering a nearly intoxicating dose of ethanol. The basis of this effect is that ethanol is a competing substrate and so it blocks the oxidation of ethylene glycol to aldehyde products. The ethylene glycol is then excreted harmlessly. Ethanol is also used as a competing substrate for treating methanol poisoning.

    Ethylene Glycol

     In competitive inhibition, the intercept of the plot of 1/V versus 1/[S] is the same in the presence and absence of inhibitor, although the slope is different. This reflects the fact that Vmax is not altered by a competitive inhibitor. Competitive inhibition can be overcome by a sufficiently high concentration of substrate. At a sufficiently high concentration, virtually all the active sites are filled by substrate and the enzyme is fully operative. The increase in the slope of the 1/v versus 1/[S] plot indicates the strength of binding of competitive inhibitor. In the presence of a competitive inhibitor the Lineweaver-Burk equation becomes:

    Competitive inhibition
    A double-reciprocal plot of enzyme kinetics in the presence and absence of a competitive inhibitor; Vmax is unaltered, whereas Km is increased.
    In other words, the slope of the plot is increased by the factor (1+[I]/ki) in the presence of a competitive inhibitor. Consider an enzyme with a Km of 10-4M. In the absence of inhibitor, V=Vmax/2 when [S]=10-4 M. In the presence of 2 X 10-3 M competitive inhibitor that is bound to the enzyme with a Ki of 10-3 M, the apparent Km will be 3 X 10-4M. Substitution of these values into Lineweaver Burk equation give V=Vmax/4.
    Noncompetitive Inhibition
    In some cases the inhibitor resembles the metabolizable substance, but it is apparently attached to the enzyme at some point other than the one which binds the original substrate, and by its antagonistic action it prevents the expected enzyme reaction.
    In noncompetitive inhibition Vmax is decreased to Vimax, and so the intercept on the vertical axis is increased. The new slope, which is equal to Km/VImax, is larger by the same factor. In contrast with Vmax, Km is not affected by this kind of inhibition. Noncompetitive inhibition cannot be overcome by increasing the substrate concentration. The maximal velocity in the presence of a noncompetitive inhibitor is Vimax.
    Noncompetitive inhibitors probably alters the conformation of the enzyme to a shape that can still bind S but cannot catalyze any reaction by forming product.
    .

    Noncompetitive Inhibition
    Uncompetitive Inhibition
    Uncompetitive inhibitors bind only to ES, not to free enzyme. In uncompetitive inhibition, Vmax is decreased by the conversion of some molecules of E to the inactive form ESI. Since it is the ED complex that binds I, the decrease in Vit1 is not reversed by the addition of more substrate. Uncompetitive inhibitors also decrease the Km because the equilibria for the formation of both ES and ESI are shifted toward the complexes by the binding of I. Experimentally, the lines on a double-reciprocal plot representing varying concentrations of an uncompetitive inhibitor all have the same slope, indicating proportionally decreased value for Km and Vmax. This type of inhibition usually occurs only with multisubstrate reactions.

    Classification of Enzymes
    There are approximately 3000 enzymes which have been characterized. These are grouped into six main classes according to the type of reaction catalyzed. At present, only a limited number are used for analytical purposes.
    Oxidoreductases
    These enzymes catalyze oxidation and reduction reactions involving the transfer of hydrogen atoms or electrons. The following are of particular importance in the design of enzyme electrodes. This group can be further divided into 4 main classes.
         Dehydrogenases catalyze hydrogen transfer from the substrate to a nicotinamide
         adenine dinucleotide cofactor (NAD+).  An example of this is lactate
         dehydrogenase which catalyzes the following reaction: 
    
                      Lactate + NAD+ = Pyruvate + NADH + H+
    
    
         Oxidases catalyze hydrogen transfer from the substrate to molecular oxygen
         producing hydrogen peroxide as a by-product.  An example of this is FAD
         dependent glucose oxidase which catalyses the following reaction: 
    
                      b-D-glucose + O2 = gluconolactone + H2O2
    
    
         Peroxidases catalyze oxidation of a substrate by hydrogen peroxide.  An
         example of this type of enzyme is horseradish peroxidase which catalyzes the
         oxidation of a number of different reducing substances (dyes, amines,
         hydroquinones etc.) and the concomitant reduction of hydrogen peroxide. The
         reaction below illustrates the oxidation of neutral ferrocene to ferricinium in the
         presence of hydrogen peroxide: 
    
                      2[Fe(Cp)2] + H2O2 + 2H+= 2[Fe(Cp)2]+ + 2 H2O   
    
    
         Oxygenases catalyze substrate oxidation by molecular oxygen.  The reduced
         product of the reaction in this case is water and not hydrogen peroxide.  An
         example of this is the oxidation of lactate to acetate catalyzed by
         lactate-2-monooxygenase. 
    
                          lactate + O2 = acetate + CO2 + H2O
    
    Transferases
    These enzymes transfer C, N, P or S containing groups (alkyl, acyl, aldehyde, amino, phosphate or glucosyl) from one substrate to another. Transaminases, transketolases, transaldolases and transmethylases belong to this group.
    Hydrolases
    These enzymes catalyze cleavage reactions or the reverse fragment condensations. According to the type of bond cleaved, a distinction is made between peptidases, esterases, lipases, glycosidases, phosphatases and so on. Examples of this class of enzyme include; cholesterol esterase, alkaline phosphatase and glucoamylase.
    Lyases
    These enzymes non-hydrolytically remove groups from their substrates with the concomitant formation of double bonds or alternatively add new groups across double bonds.
    Isomerases
    These enzymes catalyse intramolecular rearrangements and are subdivided into; 
    
                                       racemases 
                                       epimerases 
                                       mutases 
                                       cis-trans-isomerases 
    
    An example of this class of enzyme is glucose isomerase which catalyses the
    isomerisation of glucose to fructose. 
    
    Ligases
    Ligases split C-C, C-O, C-N, C-S and C-halogen bonds without hydrolysis or oxidation. The reaction is usually accompanied by the consumption of a high energy compound such as ATP and other nucleoside triphosphates. An example of this type of enzyme is pyruvate carboxylase which catalyzes the following reaction:

    pyruvate + HCO3- + ATP = Oxaloacetate + ADP + Phosphate
    An important aspect of catalytic action is the requirement by certain enzymes of either co-factors or prosthetic groups. Co-factors receive redox equivalents, protons or chemical groups from the substrate during the course of the enzymatic reaction. They tend to associate with the enzyme in a transient manner and can diffuse away from the active site. Examples of this type of molecule include NAD+ and NADP+.
    Prosthetic groups have similar function to co-factors with the exception that they are tightly bound to the enzyme. When they are released, the enzyme is mostly denatured. Flavin nucleotides and hemes are the most important examples of this class of molecule.
        Listed below are examples of co-factors and prosthetic groups.
      
        Compound                                     Function
        Nicotinamide adenine dinucleotide (NAD+)     hydrogen transfer
        Flavin mono nucleotide                       hydrogen transfer
        Flavin adenine dinucleotide (FAD)            hydrogen transfer
        Heme                                         electron transfer
        Ferredoxins                                  electron transfer, hydrogen activation
    


    Monoclonal Antibodies


    The production of monoclonal antibodies (MAbs) was pioneered by Georges Kohler and Cesar Milstein at the laboratory of molecular biology at Cambridge. For this significant achievement they were awarded the Nobel Prize in Physiology or Medicine in 1984. The technique they developed allowed the production of large quantities of homogeneous antibody against almost any antigen. MAbs have been one of the most powerful and widely used technologies in both research and medicine. They were christened magic bullets.

    What are Monoclonal Antibodies?

    MAbs are all produced from descendents of a single ancestral hybridoma cell and are identical. They only recognize a single specific antigenic determinant or hapten. They are secreted continuously by hybridoma cells in culture. Antibodies are made up of 4 polypeptide chains (2 heavy and 2 light) and these make up the characteristic Y-shape. Below are 3 diagrams showing the very basic structure of an antibody and how it interacts with antigen.


    Diagrams kindly reproduced from slides from Dr. Anne White


    There are many advantages of MAbs which make MAbs useful in a number of applications.

           They are of one defined specificity. 
           They can be produced indefinately by cells in culture. 
           Large quantities of antibody can be obtained from hybridomas grown in mice. 
           The immunogen need not be pure. 
           They cut down on the number of lab animals required. 
    
    The alternative to using MAbs is using polyclonal antisera, however this had a number of disadvantages:

           It is a mixture of antibodies of high and low affinity antibody populations. 
           It is a mixture of antibodies of different specificities. 
           The supply is limited to the life span of the immunized animal. 
           The quantity that is produced is small. 
           The immunogen has to be pure. 
    
    This limits the use of polyclonal antisera and advocates the use of MAbs. 
    
    Production of MAbs

    The Original Method Devised By Kohler and Miltstein

    Below is a diagram to summarize the method they developed. Click on different areas of the diagram to obtain further information.



    Four basic steps were involved:
           The generation of B-cell hybridomas by fusing antigen-primed B cells and myeloma cells. 
           Selection of the fused clones. 
           Screening of clones for antibody secretion with desired antigenic specificity. 
           Propagation of desired hybridomas.
    
    Production of Human MAbs

    There are many problems with using MAbs from different species like mice for applications in humans. The production of human antibodies has received much attention. Despite the efforts of many in this field, it has been difficult, but not impossible. Simply carrying out the same conventional method devised by Kohler and Milstein is not really an option. People are not able to be immunized with the same range of antigens as they have been able to do in the mouse or other species. To overcome this they have primed B cells in vitro, but the different microenvironment means that only low affinity IgM antibody is produced. One cannot just remove the spleen of a human, thus hybridomas must be prepared from peripheral blood, and this contains very few primed B cells. There is a lack of human myeloma cells that exhibit immortal growth. One must devise a different method to obtain human MAbs.

    One way is to transform human B cells with the Epstein-Barr Virus (EBV) - which confers immortality to the cells. The lymphocytes are cultured with antigen in the presence of EBV. A small proportion will be immortal and secrete antibodies.

    Another way is to incorporate the genes incoding human antibody in a SCID (Severe Combined Immunodeficiency) mouse. The mice can then be immunized and activated human B cells can be isolated from the spleen, but there is still the problem of a lack of human myeloma cells that can be used.

    Finally, there is the option of producing engineered MAbs.

    Production of Engineered MAbs

    The traditional methods have not changed much since their original description. New technologies such as genetic engineering and computer modelling have made it possible to produce MAbs in completely novel ways. The undesirable consequences of using other species MAbs in humans could be eliminated by using engineered MAbs. Engineered MAbs could finally realize the full potential of these magic bullets.

    The production of engineered MAbs can be divided into 2 main groups:
            Chimeric and hybrid antibodies. 
            Phage display antibodies.
    
    Chimeric and hybrid MAbs

    These engineered antibodies are a combination of both human and mouse antibodies. They are commonly referred to as humanized. It allows MAbs to be produced of an identical specificity as well characterised mouse MAbs. Originally, the variable region sequences were cloned from a mouse antibody gene along with the genetic informaton needed for it to be expressed, plus the constant regions from human antibody gene. These are then combined and the engineered antibody is a human-mouse chimera. The antigenic specificity is determined by the mouse variable region DNA, while the isotype is determined by the human constant region DNA. It is now possible to produce chimeric anitbodies with just mouse CDRs via a process called 'CDR-grafting'. In this process the murine CDRs are grafted onto a Fc/Fv framework.

    The engineered antibodies have fewer mouse antigenic determinants and are less likely to illicit an immune response. CDR-grafted antibodies have the least. This increases the chances for therapeutic uses of MAbs in humans. Another advantage is that the antibody retains the effector region from the human constant region.

    Phage display

    Phage display was developed at the beginning of the 1990's, and has revolutionized the generation of MAbs. The development of phage display has now made it possible to consider the isolation of human antibodies directly without immunization. Recent advances in the field of human immunogenetics and in phage technology have led to the assembly of "naive" human repertoires in vitro as complex as the natural immune system. In this method cDNA antibody variable regions are obtained and expressed as a part-molecule (FV) on the surface of a M13 filamentous phage. These phage are then used to infect bacteria, and the FV protein of defined specificty and affinity is secreted in large amounts into the culture medium.

    Applications of MAbs

    There is a large range of applications for monoclonal antibodies. These include:
            Immunoassay and Immunodetection 
            Immunocytochemistry 
            Immunoprecipitation 
            Immunoblotting 
            Immunoaffinity Purification 
    
    Immunoassay

    In the process of immunoassay a factor is quantitated on the binding of specific antibody. The antibody is labelled with something that can be measured and then compared to a calibration curve. Widely used examples include ELISA (Enzyme-Linked-Immuno-Sorbent-Assay) and RIA (Radio-Immuno-Assay). For an assay to be successful it needs to be:
           highly sensitive 
           have low non-specific binding 
           able to assay a large number of samples in a short time 
    
    Immunocytochemistry

    Immunocytochemistry uses labelled antibody which binds specifically to a molecule of interest in a fixed cell or tissue mounted on a microscope slide. The antibody can be labelled with a number of things, commonly a fluorescent molecule, that can be used to visualize certain aspects of a cell like cell surface markers which cannot normally be distinguished. MAbs are used because their specificity is defined, and one may be sure when one uses MAbs that only the molecule of interest will be bound.

    There are four steps involved:
           Cell or tissue preparation 
           Fixation and preparation of thinly sliced sections on slides
           Antibody binding 
           Detection 
    
    Immunoprecipitation

    This is the process in which antibody precipitates a factor which has been labelled and isolated from cells. It can also be used to identify antigens in a complex mixture, like immunoblotting. It is sometimes required because the antigen can become denatured and some of the epitopes destroyed during immunoblotting. Immunoprecipitation can be used with soluble antigens or with cell-surface antigens. The test antigen is labelled with I-125, the MAB is added and only binds to the one specific antigen and forms AB-Ag complexes. The complexes are precipitated out using a co-precipitating agent (e.g., Staphylococcal A) and spun out and washed to remove unbound antigens. The precipitate is resolubilized in a seperation gel and the protiens of the immune complex are separated. They are then autoradiographed to show the posistion of the bound antigen.

    Immunoblotting

    This process involves the characterization of a factor based on the MW and ability of antibody to bind to it. It is used to identify and characterize antigens from a complex mixture. The antigen samples are resolved by seperation in an analytical gel such as dodecyl sulphate (SDS), peptide mapping gels, or isoelectric focusing gels. The resolved molecules are transferred electrophoretically to a nitrocellulose membrane in a blotting tank. The blot is then treated with a MAb to the specific antigen in question. This is then washed and treated with a radiolabelled conjugate, which detects the bound antibodies. This is then washed again and put in contact with a X-ray film to produce an autoradiograph. The bands of antigen that have been bound by the MAbs are visible.

    Immunoaffinity Purification

    In this process an antibody on a column isolates a factor from a mixture. It allows the purification of a substance from 1,000 to 10,000-fold.


    Image kindly reproduced from a slide from Dr. Anne White.


    Uses of MAbs

    The many uses for monoclonal antibodies can divided up into three main areas:
           Research
           Diagnostics
           Therapeutics
    
    Research

    MAbs have much potential for research in all areas of Biology. They allow one to detect and visualise cell components or molecules. For example, cell surface markers - such as those which helped to identify the different subsets of T cells. They can visualise the distribution of molecules in cells; for example they have been able to visualise the presence of the different types of molecule, e.g. actin, tubulin in the cytoskeletons of cells.

    Diagnostics

    MAbs have had most success in the field of diagnostics. MAbs can be used to detect even the very smallest quantities of a substance. Because of their high degree of specificity one can be sure that diagnostic tests that use MAbs will be highly accurate. The use of MAbs in diagnostics have allowed a high degree of standardization and precision. Examples of where they have been used as diagnostic tools:
           Blood and tissue typing - important in blood transfusions and transplantation. 
           Quantification of T cell levels in HIV patients 
           A screening test for prostate cancer - The PSA test 
           Diagnosis of microbial infections - it identifies the organism involved 
           Pregnancy testing - MAbs detect the human chorionic gonadotrophin hormone 
           A screening test for HIV. 
    
    Therapeutics

    Most excitement in this area has been the potential treatments for cancer, though so far there has been limited success. Immunotoxins are one of a new class of drugs undergoing clinical trials for the treatment of leukaemia. They are conjugated antibodies carrying a toxin such as ricin, and specifically target cancer cells. The toxin would inactivate the cell's ribosomes and inhibit protein synthesis. As the toxin does not attack the whole cell, only small amounts are required.

    Centrifugation


    One of the most common pieces of equipment used to separate materials into subfractions in a biochemistry lab is the centrifuge. A centrifuge is a device that spins liquid samples at high speeds and thus creates a strong centripetal force causing the denser materials to travel towards the bottom of the centrifuge tube more rapidly than they would under the force of normal gravity.
    Types of centrifuges. The major distinguishing features between centrifuge types are speed and capacity. In a typical biochemistry laboratory you will find three different centrifuges (this is true in your biochemistry teaching lab as well). The smallest are the so-called microfuge centrifuges. These are made for spinning 1 to 2 ml plastic centrifuge tubes at speeds up to 12 or 13 thousand rounds per minute. They have very small, light rotors in them (the rotor is the part of the centrifuge that contains the holes for the sample tubes) which speed up and slow down rapidly. These centrifuges are very convenient for low to medium speed centrifugation of small quantities of material.
    The next common size centrifuge is the large superspeed centrifuge. These have speeds up to about 20,000 rpm and can take tubes of various sizes, depending on the rotors (the larger the rotor, the slower the maximum speed). Typical tubes hold 25 or 30 mls but bottles as large as several hundred mls can be run with the correct rotor.
    Finally, most biochemistry laboratories have access to an ultracentrifuge. Speeds up to 70,000 rpm are available on typical modern versions. Again the size of tube and the maximum speed vary from rotor to rotor, but tube sizes up to about 60 mls are available.
    The theory behind centrifugation. The idea here is pretty straight forward and mechanical. If you want the more dense materials to be separated from the less dense materials, you need a force that differentiates between particles of different density. Think about a swimming pool with a rock and a piece of styrofoam. The rock is denser than water and thus it sinks. The styrofoam is less dense than water, and thus it floats. Density is of course mass per unit volume. So, if you have a bag full of rocks and styrofoam and you want to separate one from the other, just dump the mixture into some water under the influence of the earth's gravity. The rocks will displace the water because they have greater mass for a given volume and gravity will pull them through the water. On the other hand, the water will displace the styrofoam because a certain volume of water weighs more than the same volume of styrofoam.
    However, there are many things that are much closer in density than rocks and styrofoam and it is much harder to separate them just under the Earth's gravity. In addition, diffusion is always at work as random motion smears out small differences due to density. To overcome this, or sometimes just to make the separation process faster, it would be nice to come up with a way of generating larger mass (density) dependent forces than are available from the Earth's gravity alone. Another way to generate a mass dependent force is to spin something. As you know from physics, a body in motion tends to continue in motion along a straight path unless some force is exerted on it to change its path. Thus in order to force something to go in a circle, we must exert force on it pulling it in towards the center. An equal and opposite force will always result, pushing out from the center. This is cetripital force, and it is just the mass of the object times the acceleration required to keep it from flying outward along a straight line. Thus, things with larger mass (for a given volume) will have a greater force exerted on them and they will move towards the outer edge of the container more quickly than the things with a lower mass per volume.
    The acceleration required to keep the object from flying outward along a straight path is given by w2r where the greek letter omega stands for the speed of revolution (see below for units) and r is the distance from the axis of the revolution to the position of the sample. To get a the force felt by the sample, we multiply this by the mass of the sample: F = mw2r, where F is the force and m is the mass. Please notice two things about this equation. It is linearly proportional to the mass of the object, but the force increases with the square of the rotation speed. Thus, going from 1000 rpm to 10,000 rpm increases the forces involved by a factor of 100.
    Some practical considerations. So let's say I want to spin two 30 mls tubes of water at 50,000 rpm. What kinds of forces are involved? Well, for comparison, consider the force that the acceleration of gravity exerts on the 30 mls of water when it is sitting on a bench top. The acceleration of gravity is about 10 m/s2 (10 meters per second squared). The mass of 30 mls of water is about 30 g or about 0.03 kg. Thus the force involved at 1 g (1 times the acceleration of gravity) is 0.3 kg m/s2 or 0.3 Newtons. How about at 50,000 rpm? First we need to do some units conversion. 50,000 rpm is 50,000/60 = 830 rounds per second. Further, in order to make the units work out, we must convert rounds per second to radians per second (there are 2p radians in a complete round or circle so multiply by this factor). This gives 5200 radians per second (this is omega in the equation). The force is mw2r so the total force is 66,000 N (assuming that the sample is about 8 cm from the center of rotation). To get the number of times greater this is than gravity along, we divide by 0.3 (see above) and get about 220,000 g's. That means that the water sample spinning at 50,000 rpm is equivalent to a 13,000 lb truck at normal gravity.
    If you look inside an ultracentrifuge, you will find that the rotor (the thing that contains the samples) is sitting on a shaft. The shaft is rather small and actually wobbly. There is no way you could suspend a 13,000 lb truck from this shaft. So how does it work? It works because of symmetry. You always must have a sample directly across from the sample of interest that has the same overall mass. Thus, the two masses and the forces on them balance out and the shaft feels no torque. The moral of the story is that you must balance tubes for centrifuge runs. For ultracentrifuge runs, you must balance the tubes very, very carefully. I usually try to get the masses within about 0.03 grams for an ultracentrifuge run. Slower centrifuges you can use an accordingly less stringent balance procedure.
    Rotors. There are many types of rotors, but most fall into one of three classes: fixed angle rotors, swinging bucket rotors and vertical rotors. Most of the time you will used a fixed angle rotor. Occasionally a swinging bucket or vertical rotor with be used, but not very often any form (swinging bucket allows the sample to swing out to the horizontal, giving the longest possible path of movement of the particles. The vertical rotors do the opposite -- they are used when a very short overall path of centrifugation is required.
    Types of centrifugation applications. There are many ways in which centrifuges are used. More often than not they are used to sediment some material leaving the rest in solution. However, one can also use two other common applications for separating materials: equilibrium density sedimentation and kinetic density sedimentation. In the first case, the material is either layered on top of or mixed into some material that can either be preformed into a density gradient or will become a density gradient when it is spun at high speed. The centrifuge is then run until the material finds its place as a band of particular density within the tube. The kinetic density methods also generally involve long runs that allow the molecule to find a region of the medium with the same density and come to equilibrium. In kinetic density sedimentation, you do not run the gradient to the end. You start with a band of your sample on top of the tube and let it progress through the density gradient for some period of time.


    Micro-Techniques



    References

    Enzyme Kinetics; Cardosi, Marco, Electrochemical Sensors Group; 2001; University of Paisley, Paisley, Scotland, U.K.
    Enzyme Kinetics, Natural Toxins Research Center; 2001; Texas A&M University, Kingsville, TX
    Flow Cytometry; Martz, E., Cote, C.; 2000; The University of Massachusetts, Amherst, MA
    Optical Microscopy (Molecular Expressions Review), Davidson, M.W., Abramowitz, M.; 1999; Florida State University, Tallahassee, FL
    The Beer-Lambert Law; The Squirer Group; 1999; The University of California, San Diego, CA



    CLS Introduction/OverviewPhlebotomy

    Search THIS ENTIRE WEB SITE for CLS technical, financial or other data >>>
    PicoSearch

    E-mail IrvingThis page is made entirely from recycled electrons.  Any similarity between this and any other page may be completely intentional.  Not tested on animals.  Void where prohibited.   Return to Irving's Home Page